From the Making to the Tuning to the Use of Chlorins for Biomedical Applications by Gonzales, Junior
City University of New York (CUNY) 
CUNY Academic Works 
All Dissertations, Theses, and Capstone 
Projects Dissertations, Theses, and Capstone Projects 
6-2017 
From the Making to the Tuning to the Use of Chlorins for 
Biomedical Applications 
Junior Gonzales 
The Graduate Center, City University of New York 
How does access to this work benefit you? Let us know! 
More information about this work at: https://academicworks.cuny.edu/gc_etds/2134 
Discover additional works at: https://academicworks.cuny.edu 






FROM THE MAKING TO THE TUNING TO THE USE OF 















A dissertation submitted to the Graduate Faculty in Chemistry in partial fulfillment of the 

















































This manuscript has been read and accepted for the Graduate Faculty in Chemistry in satisfaction 




Date      Charles Michael Drain 
Chair of Examining Committee 
 
 




















Advisor: Charles Michael Drain 
 
Chlorins are porphyrins missing a double bond. These pigments are optimal platforms for 
the development of novel dyes that display drug-like attributes such as photodynamic therapy 
(PDT) agents. More recently, it was demonstrated that chlorins can serve both as a PDT agent and 
as a modality for fluorescence or PET imaging. Thus, multifunctional chlorins eliminate the 
differences that may occur in specificity, uptake, and distribution between separate compounds or 
constructs for imaging and therapy. The overall goal of this dissertation is to take advantage of the 
reputed intrinsic attributes of chlorins as a viable tool in biomedical applications. In this endeavor, 
we demonstrate that three successive click reactions yield multifunctional chlorin platforms 
appended with either S-linked or O-linked polyethyleneglycol chains (S-PEG or O-PEG, 
respectively) and a carboxylate-linker to a free base of a pyrrolidine ring form from a 1,3-dipolar 
cycloaddition. This strategy allows rapid conjugation to biological and biotargeting motifs. As a 
demonstration, the soluble chlorin platforms were conjugated to lysozyme and to an amino 
terminated tether on a short oligonucleotide. These multi-purpose chlorins possess stability to 
bleaching and their photophysical properties allow use as biomolecular trackers, photodynamic 
therapy agents, and for fluorescence diagnostic imaging. Chelation with zinc(II) further modulates 
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the photophysical properties. It is our desire that our studies and findings contribute to the body of 
knowledge of chemists, clinicians, technicians and physicians in a manner that sets a precedent as 
a stepping stone to produce the next generation of chlorins that are beneficial for diagnostics and 
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CHLORIN PLATFORMS AS TOOLS FOR BIOLOGICAL AND 
BIOMEDICAL APPLICATIONS  
1.1 Introduction 
  Porphyrins are macrocycles that have brought interest due to their intrinsic chemical 
properties to be applicable in treating human disease.[4-6] Porphyrinic molecules possess 
attributes that range from environmental pollutant remedies, solar energy harvesting, sensors, 
fluorescence tracking, cargo delivery agents and therapeutics.[7, 8] In the same direction, 
established therapies and current research demonstrate that the versatile, multi-purpose 
porphyrinic macrocycles (porphyrins, chlorins, bacteriochlorins and isobacteriochlorins) can be 
optimal platforms (Figure 1.1) for the development of an array of diagnostics, imaging agents, 
and therapeutics.[9-11]  
  Chlorins are dihydroporphyrins, they are comprised of three pyrrole rings and one pyrroline 
ring.[12] Of these, the chlorins with conjugated targeting moieties, e.g. for cancer and viral 
infections, show exceptional promise in specificity, uptake, and biodistribution.[13-17] The 
multifunctional properties of the chlorins include fluorescence for imaging, binding of radio 
nuclide metal ions,[18] and efficient formation of the triplet state, facilitates the development of 
constructs that minimizes differences between separate compounds for imaging and for 
therapies.[5, 19] Chlorins possess a strong absorbance near 650 nm where light penetration of 
tissue is good (the therapeutic window is about 650-850 nm), yet the wavelengths of light are 
energetic enough to produce the photodynamic affect.[14, 15, 20]   
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  Ongoing research shows that chlorins have a good balance between fluorescence quantum 
yields and intersystem crossing to the triplet state.[4, 21] Thus, they can be used both for 
fluorescence imaging, and to sensitize the formation of singlet oxygen in good quantum yields. 
These photonic properties and characteristics make them overall better photosensitizers than the 
parent porphyrin dyes, and attractive for use in photodynamic therapies (PDT). In this scenario, 
chlorins have been demonstrated to be excellent multifunctional platforms to append targeting and 
therapeutic motifs using click chemistry and other high yield reactions, so the preparation of new 
chlorin-biotargeting constructs can be rapid and straightforward.[19, 21-23] Taking advantage of 
the functionality of chlorins leads to possible detection, imaging, treatment, and post-treatment 
monitoring human disease. For instance, chlorins can be used in the treatment of cancer, viral 
infections and inflammations.[13, 14, 20, 24] In this regard, chlorin platforms are attractive and 
can potentially sense and to treat diseases: (i) targeting the chlorin to diseased cells/tissues by 
appending multiple copies of targeting motifs to the macrocycle, and (ii) the multifunctional 
properties of chlorins, e.g. photophysical properties and metal ion binding properties, can be used 
to image the disease by fluorescence or positron emission tomography (PET) and to treat the 
disease by PDT.[5, 18, 25, 26]  
  Thus, efficient alteration of the periphery with multiple copies of targeting motifs can result 
in cooperative chemical interactions with the diseased cell or tissues that can be advantageous in 
a scaffold and can be exploited to treat distinct human diseases.[19, 23] Investigating the 
contributions of the individual portions of the chlorin macrocycle can provide us with information 
on how to fine tune the photophysical properties of chlorin for the aforementioned 
applications.[27, 28] However, in order to achieve this objective, we must first understand how 
structural changes to the chlorin will affect its electronic distribution and properties. We chose the 
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chlorins as a platform because we want to take advantage of their known benefits and to reduce 




























Figure 1.2. A multifunctional chlorin that can be tuned for distinct biomedical purposes. For 




1.2 Chlorin Platforms as Multifunctional Molecular Systems 
Multifunctional molecular systems, for instance chlorins, in the clinic and in trials, have 
many potential advantages over single-function systems in that targeting, diagnosis, imaging, and 
treatment modalities can be incorporated into a single agent.[5] The strategy of combining multiple 
components or functions minimizes differences that may occur in specificity, uptake, and 
distribution between separate compounds or constructs. Thus, this approach enhances the 
pharmacodynamics of the macrocycle.[19] A common idea in the field that originated in the 
Hunter College laboratory is that the molecular design principles for the preparation of chlorins 
should be tailored for the facile chlorin conjugation with targeting biologicals, for example, for the 
noninvasive imaging of cancer tumors and in detecting circulating tumor cells and for sensing viral 
infected cells.[30, 31] For example, if an aptamer that targets specific cancer is used, the aptamer 
targets multiple copies[32, 33] of uniquely overexpressed proteins on cancer cells and the 
porphyrin imparts several options for detection functions that can be present in a disease. The 
known attributes of chlorins (as long as the core and reduced pyrrolidine remain in tact, Figure 
1.2) make them excellent candidates for new approaches for bioanalytics and other biomedical 
applications.[19, 23] 
All the aforementioned properties and benefits of chlorins would not be possible and 
advantageous without the unique, planar topology present in the chromophore. The characteristic 
saturation on the beta position of one of the pyrroles of the macrocycle make the chlorin distinct 
from the parent porphyrin. The 18 ߨ-electrons aromatic circuit is shown in Figure 1.1, and the 
frontier orbitals (HOMOs and LUMOs) in figure 1.3. Unique characteristics of chlorin electronic 
spectra are represented by a strong absorption band in the violet-blue region with signals around 
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420 nm, the Soret band, and by absorptions on the red region with 2-4 bands between 590 and 650 
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Figure 1.3. Frontier molecular orbitals of the optimized molecular structures for the N-CH3 




1.3 Chlorin Synthesis 
The chlorin synthesis has gained attention due to their reputed attributes and potential 
applications.[19, 28, 35, 36] Nowadays, there exist several distinct approaches for the preparation 
of chlorins that range from simple redox reactions,[12] to more elaborate multistep procedures.[23] 
The choice of synthetic routes is contingent on a variety of factors that includes overall yields, 
facile synthesis, purification and characterization, availability of starting materials, total scale of 
the reaction, costs and organic chemistry methods, style and skills.[1] What is current in the field 
and the general idea for the product formation (keeping in mind overall yields) is that an elegant 
synthesis based on commercially available starting material is oftentimes preferable to those less 
elegant, multi-step synthetic approaches or those using toxic reagents such as OsO4.[19, 37] With 
any route, several unwanted possible products form and they need to be separated to afford the 
desired dye.[22, 23] The formation of the side products can be understood from the fact that there 
are four reactive pyrrole double bonds on the chromophore. This means that if the double bonds 
are not protected by functional groups, unwanted products (typically bacteriochlorins, 
isobacteriochlorins) can form after the first pyrrole reacts.[4]  
The synthesis and the tuning of chlorin properties are fine processes that requires a balance 
between maintaining the photophysics and the installation of exocyclic motifs to improve chemical 
properties to afford potent chlorin conjugates with fluorescence, PET and PDT properties.[31, 38-
40] The construction of the understanding of both natural and synthetic chlorin forming reactions 
can be quite challenging and a manner of taste.[23] For instance, Tomé and coworkers have 
constantly reported the synthesis of chlorins using classical 1,3-dipolar cycloaddition reactions,[1, 
30, 41] in a reaction that uses an ylide that is formed from the reaction of sarcosine and 
paraformaldehyde in situ.[42, 43] During the initial reaction, electrons from the ylide bond in a 
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concerted manner to form the pyrrolidine ring of the chlorin. Silva et al were able to synthesize 
chlorins using microwaves[3, 41] in a process that yields similar profiles as the thermal approach. 
Most of the several reproductions of this approach support the concerted mechanism.[23, 29, 36, 
44] However, the specific reaction conditions, e.g. the concentration, for the formation of chlorins 
by ylide chemistry play a critical role in their formation. Very dilute reactions for the preparation 
of chlorins favor mono adducts, while the use of concentrated solution for longer periods of time 
affords the di and tri adducts that exhibit high polarities.[23] The use of microwaves in general 
provides similar results in comparison to the thermal methods.[22, 45] The synthesis of chlorins 
started with the fantastic synthesis of chlorophyll a by Woodward. Jacobi, Montforts and Lindsey 
have contributed to the synthesis of chlorins and/or derivatives with great success; they were able 
to prepared chlorins featuring a gem-dialkyl pyrroline.[12, 46, 47]. Other methods to access 












Figure 1.4. Approaches to access synthetic chlorins, annulations, cycloadditions and breaking 
and mending.  
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1.4 Photodynamic Therapy (PDT) 
PDT is an approach that was discovered over a century ago. The method has become an 
accepted treatment for a range of diseases such acne, cancer, viral infection and inflammations. 
The general idea in photodynamic therapy is that a photosensitizer is introduced into the target 
sites, accumulated, and activated by the application of a specific wavelength of light or white 
light.[6] Dye precursors that are enzymatically processed into the dyes in the diseased tissue are 
also known.[15, 48] The activated photosensitizer has two routes, it undergoes energy transfer 
reaction to produce free radicals (Type I path)[49, 50] or it undergoes excitation energy transfer to 














Figure 1.5 Most common mechanism for the generation of singlet oxygen for the effecting of 




Despite the grounding facts that chlorins possess privileged attributes and features, they have 
drawbacks, for example: 
• No bio targeting motifs. 
• Many are mixture of isomers. 
• No ability to tune pharmacokinetics. 
• Most derivatives are insoluble. 
• Many photobleach. 
• Most are either PDT agent or fluorescence imaging agents but not both. 























The synthesis of chlorin and its derivatives is still a fertile area of ongoing research. The 
outcomes are expected to bring and produce new, controllable, enhanced and potent structural 
multifunctional platforms for a diverse array of biomedical applications. Other chromophores are 
also amenable for these applications, but have different photophysical properties, for instance, 
perfluorophenyl corroles.[51-53] Both past syntheses and new approaches should retain desirable 
photophysical properties, for instance red-region absorptivity for tissue penetration in 
photodynamic therapy. Moreover, concise synthetic routes for the preparation of chlorins with 
stereoselectivity and regioselectivity on the pyrroline ring are important. For instance, to avoid 
diastereomers when possible in designing the chlorin platforms.[4] In this regard, nonsymmetrical 
and non-coplanar exocyclic moieties used to modify the chlorin need to be circumvented, so that 
sets of diastereomers on the beta pyrrolic positions are not formed.[22]  
To take  advantage of the reputed properties of chlorins, the preparation of their derivatives 
must feature tethers and moieties that enable them to conjugate to other important biomolecules, 
e.g. for targeting.[54] This approach will yield more potent and multifunctional chlorin conjugates 
for imaging,[5, 55] detection and use in photodynamic therapy. For this endeavor, click group 
functionalities such azides, carboxylates, isocyanates, amines, alcohols and thiols can be used to 
yield chlorins with the features that are needed to avoid some common drawbacks present in first 
generation photosensitizer, for instance cytotoxicity at undesired sites in the body.  
The synthesis, purification and structural elucidation of these chlorin platforms is a 
complex knitting where extra observation skills from the chemist are required. Most often the 
purification process is like a puzzle where patience is required for the correct assigning of the 
molecular structure. In this regard, one needs to correlate the presence of pyrroles to pyrrolines to 
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pyrrolidines with the absorption spectrum to elucidate and to understand the required features that 
make the dihydroporphyrin a chlorin.  
One must remember that these macrocycles can give undesired side products.[23] It is also 
known that chlorins have a tendency to aggregate by forming π-stacks.[56] For this reason, the 
isolation is a delicate process, and perhaps that is why the entire process from designing to 
synthesis and to elucidation affords privileged chromophores with multifunctional properties. On 
another note, the derivatization of the chlorins must be a process where the core porphyrinoid is 
not affected by the usage of reagents in the synthesis.  
The work presented here aims to incorporate necessary features onto the chlorin 
macrocyclic, we have designed a synthetic chlorin that is water soluble, stable to photobleach, 
pharmacokinetically tunable and targeting motif available. This is how the preparation of these 
improved chlorins will contribute to the advancement of synthetic chlorin chemistry, 
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FACILE SYNTHESIS OF CHLORINCONJUGATES BY A SERIES 





The syntheses of chlorin conjugates is described and reported. Starting from meso 
perfluorophenylporphyrin (TPPF20), the chlorin featuring a pyrrolidine ring was prepared using a 
classical dipolar cycloaddition, the later chromophore was reacted with succinic anhydride to yield 
the chlorin acid. The former moiety was then solubilized using ether and thiol chains. For this 
endeavor, three successive click reactions yield multifunctional chlorin platforms appended with 
either S-linked or O-linked poly(etheleneglycol) chains (S-PEG or O-PEG, respectively) and a 
carboxylate-linker to allow rapid conjugation to biological and biotargeting motifs. As a 
demonstration, the chlorin platforms were conjugated to lysozyme and to an amino terminated 
tether on a short oligonucleotide. The stability to bleaching and photophysical properties of the 
chlorin allow fluorescence diagnostic imaging, use as biomolecular trackers, and as photodynamic 
therapy agents. Chelation with zinc(II) further modulates the photophysical properties. Standard 
NMR spectra, mass spectrometry, fluorescence and UV-visible spectroscopy was taken and they 
were consistent and in agreement with those previously reported. The NMR data for both PEG 
derivatives are somewhat complicated.  
                                                          
This Chapter is adapted from article in The Royal Society of Chemistry 1.  Gonzales, J., Bhupathiraju, N. V. S. D. K., 
Perea, W., Chu, H., Berisha, N., Bueno, V., Dodic, N., Rozenberg, J., Greenbaum, N. L., Drain, C. M., Facile synthesis 




Chlorins are macrocyclics, also known as reduced porphyrins.[2] Naturally, chlorins are 
pigments associated with chlorophyll, these chromophores are responsible for the green color in 
plants. Manmade chlorins (Figure 1) are often obtained by oxidative or reductive alterations of 
porphyrins. Many porphyrinoid compounds have been reported as potential next-generation 
photodynamic therapy (PDT) agents over the last two decades, and more recently as 
fluorescent dyes for biochemical trackers, diagnostics, and imaging.[3-6] In addition to 
cytotoxic agents for cancer, porphyrinoids are being developed as antiviral and antibacterial 
agents.[7] The optimal properties of biomedical dyes include: chemical purity, amphipathic 
solubility, strong red light absorption to maximize light penetration into tissues, tunable 
photophysical properties for imaging by fluorescence or therapy via sensitization of the 
formation of singlet oxygen, selectivity to diseased tissues such as cancer, or to bacteria but 
with minimal accumulation in non-target tissues, and minimal dark toxicity.[8] However, de 
novo porphyrinoid synthesis is difficult because of low yields and tedious purification. 
Moreover, chlorins have excellent photophysical properties for the aforementioned 
applications that include a strong red absorption around 650 nm, a balance between the 
singlet state and intersystem crossing to the triplet manifold, and the y  can be stable to 
photo-bleaching.[9] The photophysical properties of chlorins enable them to be used 
concomitantly for diagnostics and therapeutics, i.e. theranostics. A mixture of the four 
atropisomers of the free base meta-tetrahydroxyphenylchlorin (m-THPC) is approved for 
PDT of some cancers in Europe and Asia; however, the lack of cancer targeting motifs limits 
applications of this compound.[10, 11] To date, neither porphyrinoids in the clinic nor in 
trials have specific biotargeting motifs appended. Though there are many reports on targeting 
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porphyrins to cancer, such as sugar and peptide conjugates, there are far fewer reports on 
biotargeted chlorins.  
The advantage of theranostics is that the same compound is used for diagnostics, 
imaging, and for therapy, thereby eliminating differences in uptake of distinct molecular 
systems.[12] Considering the large chemical diversity of biotargeting motifs, it is desirable 
to create modular, multifunctional theranostic platforms that can be readily adapted to the 
many forms of cancer, to specific bacteria, or use in other photonic bioanalytic 
applications.[13] Modular systems allow facile optimization of each of the components, dye, 
linker, targeting, photonic properties, solubility, binding affinity/specificity, and 
pharmacokinetics.[14] 
While chlorins such as m-THPC display good singlet oxygen quantum yields for 
PDT, non-specific accumulation in the skin results in significant photosensitivity. De novo 
synthesis of chlorins appended to biological targeting motifs with tunable solubility are 
difficult to synthesize. When the chlorin is formed using chemistry that results in pyrrolidine 
N-H or N-R- groups on the β positions of a pyrrole, an additional issue is that targeting motifs 
with chiral centers appended to the meso positions result in the formation of diastereomers 
(scheme 2.3).[2, 15]   
This chapter will focus on the design, synthesis, elucidation and bioconjugation of 
chlorins to biomolecules as a proof of principle for the preparation of potent photosensitizer 
agents to treat disease. In this line, we provide a synthetic route to a chlorin platform 
(Scheme 2.1)[16] for the modular construction of targeted diagnostics, therapeutics, and 
trackers[10] that exploits well-established linking protocols so that both the 
solubility/pharmacokinetics and the targeting motifs can be modulated by rapidly and 
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efficiently appending exocyclic groups. This allows researchers to concentrate on the role 
of the biotargeting motif[17] and tuning the pharmacokinetics rather than the de novo design 
and synthesis of new dye systems for cancer,[5] viral- infected cells,[18, 19] and bacterial 
infections.[20] 
To obviate the design of new synthetic strategies and enable rapid development and 
deployment of chlorins in the aforementioned applications, we report herein a modular chlorin 
platform that uses successive click reactions to rapidly and efficiently append diverse 
biotargeting motifs and diverse polyethylene glycols (PEG) onto the dye. Thus, the well-
known properties of PEGs to modulate small molecule solubility, pharmacokinetics, 
targeting, and reactivity are also readily exploited.[21] 
As a demonstration of the sequential click reactions used to make the photonic dye 











Scheme 2.1. (i) glycine/paraformaldehyde (1:1), added in four aliquots in chlorobenzene, 
145 oC, 8 h, 36% yield. (ii) 5 equiv. succinic anhydride, CH2Cl2, NEt3, 25 oC, overnight, 
95% yield.  
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perfluorophenyl chlorin, the chlorin appended with four 2-(2- methoxyethoxy)ethanol 
groups (O-PEG) and the chlorin platform appended with four 2-(2-
methoxyethoxy)ethanethiol (S-PEG) groups at the 4' positions of the meso perfluorophenyls 
(Scheme 2.1).[2, 22] Furthermore, these chlorins feature a carboxylate linker tethered to the 
nitrogen of a fused pyrrolidine ring used to make and stabilize the chlorin. The carboxylate 
is readily activated by the N-hydroxysuccinimide group to enable clicking onto amines of 
biomolecules or biomolecular recognition motifs. 
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Scheme 2.1. (iii) for HS-PEG, 4.5 equiv. 2-(2-methoxyethoxy)ethane thiol and stoichiometric 
K2CO3 in acetone, 25 oC, 6 h, 85%; for HO-PEG 10 equiv. 2-(2-methoxyethoxy)ethanol and 
stoichiometric K2CO3 in dry acetone, reflux, overnight, 85%. (iv) 1.2 equiv. N-
hydroxysuccinimide in dioxane or tetrahydrofuran with 1.2 eq. dicyclohexylcarbodiimide at 25 
oC, overnight, quantitative yield. (v) bio-conjugation depends on the specific targeting molecule 
but is generally accomplished in buffer or DMSO at 25 oC for 2-10 hr. Chlorins were reacted in 
a 5 µM solution of a 14 nt DNA with an amino terminated tether (10:1 ratio; 5'-NH2-(CH2)6-NH-
TTCTTCTCCTTTCT-3'), pH 7.4 phosphate buffer overnight, 37 oC. For the lysozyme 
(hydrolases) conjugate, a 100 µM solution of 7 or 8 was allowed to react with lysozyme in DMSO 
over night at room temperature and purified by gel filtration on a 5 mL column of Sephadex 
G-25 with water as eluent. 
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2.2 Experimental Procedure 
Materials and Methods: 
General 
1H and 13C solution NMR spectra were recorded using Bruker 500 MHz (spectrometer 
operating at 500 MHz for 1H; 125 MHz, for 13C), and 19F solution NMR spectra was recorded 
using Bruker 400 MHz. CDCl3 was used as solvent and TMS as internal reference; the chemical 
shifts are expressed in (ppm) and the coupling constants (J) in Hertz (Hz). Trace solvent impurities 
(eg. water at approx. δ 1.6 ppm, dichloromethane (DCM) at approx. δ 5.2 ppm in 1H NMR spectra) 
are indicated. High Resolution Electrospray Mass Spectra (HRESIMS) were obtained using an 
Agilent 6520 Q-TOF instrument and using CH2Cl2 as a solvent. The UV-vis spectra were recorded 
using CH2Cl2 as solvent, on a Perkin-Elmer Lambda 35 UV-visible spectrometer. Reagent grade 
chemicals and solvents were purchased from Sigma-Aldrich Inc. or Fisher Scientific Inc.  
Reactions were monitored by TLC with Analtech Uniplate silica gel G/UV 254 precoated plates 
(0.2 mm).  TLC plates were visualized by UV (254 nm), and by iodine vapor. Preparative thin-
layer chromatography was carried out on 20x20 cm glass plates coated with silica gel (1 mm thick). 
Adapted from reference 1. 
Synthetic Outline 
5, 10, 15, 20-tetrakis-(2,3,4,5,6-pentafluorophenyl)-porphyrin TPPF20 (100 mg, 0.102 
mmol) dissolved in chlorobenzene (10 mL) was reacted with 10 equivalents of an azomethine ylide 
prepared by grinding a mixture of glycine (77 mg, 1.05 mmol) and paraformaldehyde (30.8 mg, 
1.05 mmol). The prepared azomethine ylide (25 mg) was added in 4 aliquots every 2 hours and 
allowed to react at 145 oC, under a N2 atmosphere. Chlorin 2 (37.5 mg, 0.036 mmol), triethylamine 
(0.5 mL, 0.004 mmol) and succinic anhydride (36 mg, 0.367 mmol) were added and stirred for 4 
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hr. in a reaction vessel at room temperature (r.t.) under a N2 atmosphere. A solution of compound 
3 (100 mg, 0.09 mmol) in acetone (12 mL) was added K2CO3 (74 mg, 0.54 mmol) and stirred for 
10 min. Next, 2(2-methoxyethoxy)ethane thiol (54.00 µL, 0.40 mmol) was added to the reaction 
mixture and allowed to react at room temperature under N2 to afford the tetra S-PEG compound 4. 
Similarly, to a solution of 3 (34 mg, 0.0306 mmol), dissolved acetone (5 mL) was added K2CO3 
(74 mg, 0.54 mmol) and stirred for 10 min. Subsequently, 2-(2-methoxyethoxy)ethanol (48 µL, 
0.40 mmol) was added to the reaction mixture and allowed to reflux under N2 to yield the tetra O-
PEG compound 5. The O-PEG-chlorin or the S-PEG-chlorin was dissolved in dioxane or THF (6 
mL) and activated with N-hydroxysuccinimide (5.06 mg, 0.04 mmol) and 
dicyclohexylcarbodiimide DCC (9.9 mg, 0.05 mmol) at r.t. under N2 to yield compounds 7 and 8, 
respectively.  
Either the S-PEG chlorin 7 or the O-PEG-chlorin 8 in DMSO and lysozyme from chicken 
egg white (SIGMA L6876) in DMSO (final concentration 100M) were conjugated at room 
temperature in the dark with constant shaking to afford S-PEG-chlorin or O-PEG-chlorin-
lysozyme conjugates. After the reaction, samples were centrifuged at 16300 xg for 5 min at 4 °C 
where no precipitates were observed, and stored at -20 °C for further analysis. The SDSPAGE 
analysis shows that that the best conditions were at 1:1 ratio (100 M each) and reaction was 
almost complete after 16 h. 
 Either the S-PEG-chlorin 7 or the O-PEG-chlorin 8 were coupled to the 5' of 14 nt DNA 
via 6 carbon amine linker (5'-NH2-(CH2)6-NH-TTCTTCTCCTTTCT-3') in phosphate buffer 0.1 
M, pH 7.4 with 10:1 ratio at 370C and the precipitate under these conditions affords S-PEG-chlorin 
or O-PEG-chlorin DNA conjugates. After the reaction, the sample was centrifuged at 16300 xg for 
5 min, whereupon the supernatant and the pellet dissolved in DMF were run on 20% 
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polyacrylamide gel, refer to appendix. The gels for S-PEG-chlorin or O-PEG-chlorin conjugates 
to DNA confirmed the coupling. A smeared band towards the top of the gel indicates some 
contribution of higher ordered labelled DNA. 
Synthesis of pentafluorophenyl Chlorin (2) 
Chlorin (2). Glycine (77 mg, 1.05 mmol) and paraformaldehyde (30.8 mg, 1.05 mmol) 
were mixed in situ for 5 min to afford the azomethine ylide adduct (107 mg). To a stirred solution 
of 5, 10, 15, 20 -tetrakis-(2, 3, 4, 5, 6-pentafluorophenyl)-porphyrin TPPF20 (100 mg, 0.102 mmol) 
dissolved in chlorobenzene (8 mL) the prepared azomethine ylide (25 mg) was added in 4 aliquots 
every 2 hours and allowed to react at 145 oC, under nitrogen atmosphere for a total of 8h. After 
cooling to room temperature, chlorobenzene was evaporated under reduced pressure and dissolved 
in 4 mL of DCM for purification by silica gel using DCM to get the unreacted TPPF20 followed 
by 7% EtOAc/DCM as eluant to furnish 36 % pure 2 (37.5 mg, 0.0367 mmol) as a dark green solid. 
1H NMR (500 MHz, CDCl3) δ 8.64 (d, J=5 Hz, 2H), 8.41 (s, 2H), 8.30 (d, J=4 Hz, 2H), 5.14 (s, 
2H), 3.28-3.25 (dd, J1=5, J2=10 Hz, 2H), 2.27-2.24 (dd, J1=5, J2=10 Hz, 2H), -1.95 (s, 2H); 13C 
NMR (125 MHz, CDCl3) δ; 151.77, 146.31, 145.59, 144.31, 143.59, 142.21, 140.16, 139.26, 
138.17, 137.45, 136.12, 135.46, 134.17, 131.34, 126.98, 122.84, 114.69, 114.24, 105.30, 95.67, 
51.32, 27.99; 19F NMR (376 MHz, CDCl3): δ -135.29 to -136.80 (m, 8F, Ar-m-F), -150.96 to -
151.64 (m, 4F, Ar-p-F), -157.21 to -161.28 (m, 8F, Ar-o-F). HRMS (refer to Appendix)  m/z calcd 
for C46H15F20N5 ([M+H]+), 1018.1081, found 1018.1091; calcd for C46H15F20N5 ([M+Na]+),  
1040.0900, found 1040.0908. 
Synthesis of chlorin acid (3) 
Synthesis of (3). To a 10 mL round bottom flask, compound 2 (37.5 mg, 0.036 mmol) was 
dissolved in 5 mL DCM and 0.5 mL NEt3 then succinic anhydride (36 mg, 0.367 mmol) was added 
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and stirred overnight at room temperature under N2 atmosphere. Then 20 mL of DCM is added the 
resulting mixture is washed with water followed by brine. The organic layer was dried using 
sodium sulfate to remove trace amount of water. DCM was removed through a rotator evaporator 
and the crude product was purified by flash chromatography (silica gel) using 3% Methanol/DCM 
as eluent to afford 85 % pure 3 (34 mg, 0.0306 mmol) as a dark green solid. 1H NMR (500 MHz, 
CDCl3) δ 8.74 (d, J=4.85 Hz, 2H), 8.50 (s, 2H), 8.38-8.42 (dd, J1=4.65, J2=4.7 Hz, 2H), 5.40-5.48 
(m, 2H), 4.17 (t, J=10.15 Hz, 1H), 4.07 (t, J=9.95 Hz, 1H), 3.74-3.77 (m, 2H), 2.50-2.54 (m, 2H), 
2.12-2.17 (m, 2H), -1.82 (s, 2H); 13C NMR (125 MHz, CDCl3) δ; 168.57, 168.51, 153.18, 152.95, 
147.26, 146.49, 145.31, 144.82, 143.34, 141.29, 140.59, 140.15, 139.15, 138.56, 137.22, 136.52, 
135.59, 135.29, 132.69, 132.64, 128.37, 128.08, 124.32, 123.80, 115.52, 115.24, 106.79, 106.50, 
96.94, 96.37, 53.68, 52.28, 52.17, 52.07, 51.34, 51.22, 51.20, 50.48, 31.76, 30.99, 29.72, 29.69, 
29.21, 28.83, 28.67, 28.55; 19F NMR (376 MHz, CDCl3): δ -134.37 (d, 1F, Ar-m-F), -135.39 (d, 
1F, Ar-m-F), -136.74 to 136.98 (m, 5F, Ar-m-F), -137.50 to -137.74 (d, 1F, Ar-m-F), -150.10 to -
150.42 (m, 2F, Ar-p-F), -151.38 to -151.49 (m, 2F, Ar-p-F), -159.02 to -159.08 (m, 2F, Ar-o-F), -
159.82 to -159.94 (m, 2F, Ar-o-F), -161.35 (s, 4F, Ar-o-F). HRMS (refer to Appendix) m/z calcd 
for C50H19F20N5O3 ([M+H]+), 1118.1241, found 1118.1238; calcd for C50H19F20N5O3 ([M+Na]+), 
1140.1061, found 1140.1048. 
 
Synthesis of S-PEGylated chlorin acid (4) 
Synthesis of (4). To a solution of chlorin acid 3 (100 mg, 0.09 mmol, 1 equiv.) dissolved 
in acetone (12 mL) was added K2CO3 (74 mg, 0.54 mmol, 6 equiv.) and stirred for 10 min. 2(2-
methoxy ethoxy)ethane thiol (54.00 µL, 0.40 mmol, 4.5 equiv.) was added to the reaction mixture 
and allowed to react at r.t. under inert conditions for 4h. Acetone was removed under reduced 
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pressure, the crude mixture was dissolved in ethyl acetate (15 mL) and washed with water (12 mL). 
The organic layer was evaporated and concentrated in vacuo. The crude product was purified by 
flash column chromatography over deactivated silica gel using 0.7% MeOH/DCM as eluent to 
furnish pure 4 as a green solid (78 mg, 60 % yield from 3). 1H NMR (500 MHz, CDCl3) δ 8.77-
8.72 (m, 2H), 8.53-8.38 (m, 4H), 5.46 (bs, 2H), 4.25-4.20 (m, 2H), 3.94-3.85 (m, 8H), 3.75-3.72 
(m, 8H), 3.68 (bs, 2H), 3.63-3.61 (m, 8H), 3.44-3.35 (m, 20H), 2.64-2.57 (m, 1H), 2.48-2.43 (m, 
1H), 2.17-2.12 (m, 2H), -1.82 (s, 2H); 13C NMR (125 MHz, CDCl3) δ; 173.90, 170.07, 152.83, 
150.09, 148.16, 146.09, 144.75, 144.01, 142.23, 140.75, 139.86, 138.45, 137.34, 135.78, 133.11, 
132.68, 128.51, 128.21, 123.39, 122.13, 114.12, 105.45, 96.03, 71.96, 71.91, 71.81, 70.92, 70.86, 
70.77, 70.67, 70.59, 70.43, 70.37, 59.0, 53.42, 52.40, 30.36; 19F NMR (376 MHz, CDCl3): δ -
136.84 (s, 1F, Ar-m-F) -137.78 (s, 1F, Ar-m-F) -138.75 to -139.25 (m, 5F, Ar-m-F), -140.07 (s, 
1F, Ar-m-F), -155.01 to -158.03 (m, 8F, Ar-o-F). HRMS (refer to Appendix) m/z calcd for 
C70H63F16N5O11S4 ([M+H]+), 1581.3151, found 1582.3214 
 
Synthesis of O-PEGylated chlorin acid (5) 
Synthesis of (5). To a solution of 3 (34 mg, 0.0306 mmol), dissolved in dry acetone (5 mL) 
was added K2CO3 (74 mg, 0.54 mmol) and stirred for 10 min. 2-(2-methoxyethoxy)ethanol (48 
µL, 0.40 mmol) was added to the reaction mixture and allowed to reflux under nitrogen overnight.  
Acetone was removed under reduced pressure. The crude product was purified by silica gel using 
7% MeOH/DCM as eluent to furnish 85% pure 5 (39.45 mg, 0.026 mmol) as a green solid. Note: 
If acetone is not dry the reaction takes longer (48 h) and excess 2-(2-methoxyethoxy)ethanol is 
required. 1H NMR (500 MHz, CDCl3) δ 8.74 (bs, 2H), 8.52 (bs, 2H), 8.42 (bs, 2H), 5.41-5.47 (m, 
2H), 4.69-4.72 (bs, 8H, OCH2), 3.98-4.03 (m, 8H), 3.72-3.83 (m, 10H), 3.62-3.66 (m, 8H), 3.34-
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3.44 (m, 14H), 2.58-2.61 (bs, 1H), 2.45 (bs, 1H), 2.10-2.19 (m, 2H), -1.86 (s, 2H) ; 13C NMR (125 
MHz, CDCl3) δ; 168.57, 168.51, 153.22, 153.18, 153.07, 153.00, 147.41, 146.63, 145.43, 144.68, 
142.52, 142.25, 141.94, 141.91, 141.82, 141.79, 140.72, 140.54, 140.35, 140.32, 139.95, 139.93, 
139.84, 139.81, 139.15, 138.91, 138.81, 135.62, 135.44, 132.59, 128.35, 128.15, 124.26, 123.85, 
113.65, 113.50, 107.43, 107.29, 97.57, 97.02, 74.49, 72.05, 71.92, 70.96, 70.83, 70.75, 70.59, 
70.46, 59.20, 59.08, 52.32, 51.33, 50.53, 29.74.; 19F NMR (376 MHz, CDCl3): δ -136.86 (bs, 1F, 
Ar-m-F), -137.84 (bs, 1F, Ar-m-F), -139.21 to -139.36 (m, 5F, Ar-m-F), -140.16 (bs, 1F, Ar-m-F) 
-154.98 to -155.80 (m, 4F, Ar-o-F), -157.02 (bs, 4F, Ar-o-F). HRMS (refer to Appendix) m/z calcd 
for C70H63F16N5O15 ([M+H]+), 1518.4138, found 1518.4101; calcd. for C70H63F16N5O15 ([M+Na]+), 
1540.3957, found 1540.3905. 
 
Synthesis of activated chlorin acid (6) 
Synthesis of (6). To a solution of 3 (50 mg, 0.04 mmol, 1 equiv.) dissolved in THF (6 mL) 
was added N-hydroxysuccinimide (5.06 mg, 0.04 mmol, 1.1 equiv.) and DCC (9.9 mg, 0.05 mmol, 
1.2 equiv.), and allowed to react at r.t under inert conditions for 45 min. THF was evaporated under 
reduced pressure and the crude dissolved in DCM (5 mL). The organic layer was washed with 
NaHCO3 (6 mL) followed an additional wash with water (6 mL). The organic layer was 
concentrated in vacuo to furnish compound 6 as a green solid (35 mg 72 % yield from 3). HRMS 
(refer to Appendix) m/z calcd. for C54H22F20N6O5 ([M+H]+), 1214.1332, found 1215.1397. 
 
Synthesis of activated S-PEGylated chlorin acid (7) 
Synthesis of (7). To a solution of 4 (50 mg, 0.03 mmol, 1 equiv.) dissolved in THF (6 mL) 
was added N-hydroxysuccinimide (4.0 mg, 0.03 mmol, 1.1 equiv.) and DCC (7.3 mg, 0.04 mmol, 
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1.2 equiv.) and allowed to react at r.t under inert conditions for 45 min. THF was evaporated under 
reduced pressure and the crude dissolved in DCM (5 mL). The organic layer was washed with 
NaHCO3 (6 mL) followed an additional wash with water (6 mL). The organic layer was 
concentrated in vacuo. The organic layer was concentrated in vacuo to furnish compound 7 as a 
green solid (32 mg 67 % yield from 4). 1H NMR (500 MHz, CDCl3) δ 8.62-8.48 (bs x2, 6H), 4.77 
(bs, 2H), 4.11-4.07 (m, 10H), 3.89-3.85 (m, 10H), 3.70-3.61 (m, 18H), 3.52-3.43 (m, 8H), 3.41 
(bs, 1H), 3.35 (bs, 1H), 3.30 (bs, 1H), 2.92 (bs, 2H), 2.36-2.33 (m, 2H), 2.31-2.29 (m, 2H); 13C 
NMR (125 MHz, CDCl3) δ; 147.37, 145.02, 135.42, 132.87, 116.41, 106.61, 71.95, 71.87, 71.82, 
70.92, 70.78, 70.64, 70.59, 70.39, 70.31, 69.73, 59.09, 53.45, 38.34, 30.36; HRMS (refer to 
Appendix) m/z calcd. for C74H66F16N6O13S4 ([M+H]+), 1678.3315, found 1679.3343. 
 
Synthesis of activated O-PEGylated Chlorin acid (8) 
Synthesis of (8). To compound 5 (39.45 mg, 0.026 mmol) in dry dioxane (3 mL) was added 
N-hydroxysuccinimide (4.0 mg, 0.03 mmol, 1.1 equiv.) and DCC (7.6 mg, 0.04 mmol, 1.2 equiv.) 
and allowed to react at r.t under nitrogen overnight. The resulting mixture is centrifuged at 13000 
rpm for 10 min and the supernatant was evaporated under reduced pressure to furnish compound 
8 (41 mg, 0.025 mmol) in 98 % yield as a green solid. The compound is used for conjugation 
without further purification as it results in free acid (compound 5). HRMS (refer to Appendix) m/z 
calcd for C74H66F16N6O17 ([M+H]+), 1615.4362, found 1615.4230; C74H66F16N6O17 ([M+Na]+), 






Bioconjugation of chlorins Outline 
Synthesis of Lysozyme Conjugate 
A mixture of S-PEG-chlorin NHS ester (compound 7) or an O-PEG-chlorin NHS ester 
(compound 8) in DMSO (final concentration 100 M) and aqueous lysozyme from chicken egg 
white (SIGMA L6876) at a PEG-chlorin:lysozyme molar ratio 1:1 was adjusted to a final volume 
of 1 mL with DMSO. The conjugation lasted overnight at room temperature in the dark with 
constant shaking. After reaction, samples were centrifuged at 16300 xg for 5 min at 4 °C (no 
precipitates were observed) and stored at -20 °C. Crude product was purified by gel filtration on a 
5 mL column of Sephadex G-25 Superfine (GE Healthcare 17-0031-01). Conjugates were eluted 
with distilled deionized water and 2 mL fractions were collected. The fluorescence of the chlorins 
allows direct visualization of the gels without staining using standard Coomassie blue protocols.  
Fractions 2 and 3 (Ve 3-6 mL) luminesced upon excitation with 365 nm UV light. Fractions were 
dried in a Speed-Vac concentrator overnight and analysed by SDS-PAGE (refer to Appendix), 
non-denaturing PAGE (refer to Appendix) and UV-Vis (refer to Appendix) after dissolving in 50 
L distilled deionized water.  Lysozyme contains lysine amino acids that can potentially react with 










Conjugation to ssDNA 
  Chlorin was coupled to 5' of 14 nt DNA via 6 carbon amine linker (5'-NH2-(CH2)6-
NH-TTCTTCTCCTTTCT-3'). Chlorin was added to 100 μM DNA containing phosphate 
buffer 0.1 M, pH 7.4 with 10:1 ratio. The reaction was carried out overnight at 37 ᵒC and 
aggregation was observed at this condition. After reaction, sample was centrifuged at top 
speed for 5 min, supernatant and pellet dissolved in DMF were run on 20% polyacrylamide 
gel as shown in Figure 1. Same position on the gel for both chlorin and DNA confirmed the 
coupling of chlorin and DNA. A smeared band from top of the gel in lane 3 might be the 
contribution of free dye and higher ordered labelled DNA. 
 
Enzymatic activity assay  
A: lysozyme in DMSO; B: O-PEG-chlorin-lysozyme conjugate in DMSO, M. lysodeikticus 
cells (SIGMA M3770 ATCC No 4698) (1.25 mL, 0.15 mg/mL) in 66 mM potassium phosphate 
pH 6.2 was mixed with 0.05 mL lysozyme or lysozyme conjugate in DMSO.  The change in 
absorbance at 450 nm was monitored for five minutes in a Cary 50 Scan UV-Vis spectrophotometer 
(Varian). The activity was calculated using the formula below: 
 
Units/mg =  ∆ A
450
/min * 1000 
                          mg enzyme 
 
 
Units/mL =  ∆ A
450
/min____ 







Cell studies with DNA Conjugate 
Confocal Microscopy. MDA-MB-231 cells were plated onto cell culture dishes. O-PEG-
chlorin-DNA conjugate 9b were prepared at final concentration of 1, 2.5, 5, 7.5 and 10 nM in 
DMEM (Dulbecco's Modified Eagle's medium). After incubation for 24 h, the cells were rinsed 
three times with phosphate buffered saline (PBS), and incubated with a 4% paraformaldehyde 
solution for 15 min at 37 °C under cell growth conditions. Cells were then washed three times with 
PBS and visualized using a Nikon Eclipse Ti microscope in Hunter's Bio-Imaging Facility. 
Excitation was 572nm+/-35nm and emission was 630+/-60nm for all samples.  
Observations: 
The images were taken at five different concentrations (1, 2.5, 5, 7.5 and 10 nM). With 
concentrations over ca. 5 nM, after incubation of the cells with 9b overnight we observed decrease 
in cell density and the morphology of the cells changed along with the clumping. Neither the DNA 
by itself nor the chlorin platform cause these morphological changes in the cells at these 
concentrations.[23] We expected the amphipathic chlorin moiety to diffuse passively into the cell 
membrane due to the PEG groups, but the DNA part of the conjugate inhibits uptake into the cell 
due to the high negative charge of DNA. Although the mechanism for the changes in cell 
morphology and necrosis induced by 9b is under investigations, we postulate that aggregates of 
the compound cause a disruption of the cancer cell membrane.  The fluorescence microscopy 
studies were conducted on the same day the cells were fixed using paraformaldehyde and 7 days 
after fixing. We observed a substantial increase in the fluorescence on day 7 compared to day 1, 
which likely indicates that 9b was aggregated in/on the cells initially, and slowly disaggregates 
after fixing, which is similar to what is observed for glycosylated phthalocyanines.[24] We also 
observed aggregates of the compound mostly on the surface or in the cytoplasm, which is in 
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agreement with our assumption that the DNA inhibits the conjugate from entering the cell and cell 
organelles. 
2.3 Results and Discussion 
In our approach the chlorins are formed by a 1,3-dipolar cycloaddition[22]  on a 
pyrrole of meso tetrakis(pentafluorophenyl)porphyrin (TPPF20) 1 using an azomethine ylide 
to afford amine 2 (Scheme 2.1)  almost  exclusively  depending  on  reaction  conditions. The 
dark green product was isolated a by two successive standard column chromatographies. A 
quick elution using dichloromethane is followed by a second elution using a petroleum 
ether/ethyl acetate eluent. The resulting fused pyrrolidine ring presents a free nitrogen base 
that is used to add the tether, in this case using succinic anhydride to yield compound 3, 
but other tethers are amenable. This approach to adding the linker on the pyrrolidine was 
pursued to avoid the formation of diastereomers that result from using substitution of the para 
fluoro group on the phenyls with chiral moieties such as sugars.[2] To make the chlorin 
amphipathic and facilitate reactions in aqueous solvents, short S-PEG and O-PEG are readily 
added to 3 to yield chlorin 4 and 5. 
Chlorins 3, 4 and 5 exhibit a terminal carboxylic acid that is readily reacted with 
N-hydroxysuccinimide to give the core chlorin platforms 6, 7 and 8. Note that the 4' fluoro 
groups can be substituted nearly quantitatively with a large menu of primary thiols, but 
amines and alcohols also react well.[14, 25] Thus other functional groups are readily 
appended to the four aryl groups of chlorin 3, e.g. to modulate solubility, charge, steric 
bulk or add secondary targeting motifs. Platform 6, 7 and 8 readily react with amine 
groups on an array of biomolecules, NMR spectra, mass spectrometry and UV-visible 
spectroscopy were consistent with compounds 2 to 8. The NMR spectrum for chlorin 2 is 
35 
 
consistent with that of the N-methyl pyrrolidine derivative previously reported.[2, 16] The 
NMR data for both PEG derivatives are somewhat complicated by the reduced symmetry of 
the chlorin resulting from the orientation of the pyrrolidine pointing toward one face of the 
macrocycle and increased molecular size, resulting in broadened multiplets for both the 
macrocycle and the PEG units. An overview of the transformation of an N-H chlorin to include 
a tether and PEG groups to tune solubility followed (monitored) by NMR is in Figure 2.3 and in 
Table 2.2 (1H) and Table 2.3 (13C).[1, 3, 26] 
The fluorescence and UV-visible spectra (Figure 2.4 and 2.5) are minimally 
perturbed from known N-methyl derivatives (Table 2.1).[2] The UV-visible spectrum of 2 in 
CH2Cl2 has a lowest energy Q band at Amax = 652 nm. The Soret bands for the S-PEG (4 
and 7) and O-PEG (5 and 8) derivatives are blue shifted by about 5 nm, indicating small 
electronic differences arising from the substitution of the four -F groups with four –S-PEG 
and –O-PEG groups. The ca. 35% fluorescence quantum yield and optical density at 
multiple wavelengths enable using the platform as a fluorescent tracker and for 
bioimaging.[9] The florescence anisotropy spectra has a maximum of 0.35 ± 0.05, making 
the compound suitable for biophysical applications based on anisotropy. As with the N-
CH3 derivatives, the present chlorin platforms are stable to photo-bleaching. 
As proof-of-concept, chlorins 7 and 8 with the activator were couple to exposed lysine 
amino groups on the lysozyme enzyme (hydrolases), and a tethered primary amine on the 
5’ end of 14 nt single strand DNA  (ssDNA),  to  give  9a,  9b,  10a,  and  10b respectively. 
The chlorin conjugation to the biomolecule was performed under standard coupling reaction 
conditions.[27] Chlorins 7 and 8 were coupled to the 5' end of 14 nt DNA via 6- carbon   
amine   linker (5'-NH2-(CH2)6-NH-TTCTTCTCCTTTCT-3'). The chlorins were added to 5 
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µM DNA in phosphate buffer (0.1 M, pH 7.4) with 10:1 ratio.  The reaction was carried out 
overnight at 37 °C. Some aggregation was observed under these conditions if greater DNA 
concentrations are used. PAGE assays confirmed the coupling of chlorin to the DNA (Figure 
2.10). 
Coupling of lysozyme to chlorin 7 and 8, in DMSO is accomplished at room 
temperature overnight in a ca. 1:1 reaction or a ca. 1:10 reaction (refer to Appendix) 
followed by gel filtration. SDS-PAGE of the purified conjugate imaged by the chlorin 
fluorescence clearly indicates that either the amino group on the N-terminal amine or one of 
the six lysine residues is conjugated to the chlorin. Small amounts of a double and triple 
labelled conjugate are observed. These conclusions are corroborated by staining the gel 
with Coomassie blue to visualize the protein at the same location in the gel as the fluorescent 
band. Electrospray ionization mass spectrometry indicates the lysozyme is appended with 
one chlorin. Importantly, activity of the enzyme is maintained after conjugation, (see 
Figures 2.6, 2.7, 2.8, 2.9 and 2.11). 
Though these are proof-of-concept conjugates, to investigate the possible uptake of 
DNA-chlorin conjugates by MDA-MB-231 breast cancer cells, we incubated 1 nM to 10 nM 
of 9b with the cultured cells for 24 hours. Afterwards, we observed a decrease in cell density, a 
change in cell morphology, and cell clumping with concentrations of 9b above 5 nM. 
Fluorescence microscopy studies indicate that the conjugates are aggregated in/on the cells 
and slowly disaggregate (Figure 2.12 and 2.13). Neither the DNA nor chlorins elicit cell 
morphology changes or death at these concentrations. 
The efficient synthetic route for amphipathic chlorins with widely used 
bioconjugation linkers yields a platform for diverse photonic applications in biochemistry, 
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biology, imaging and therapeutics.  S-PEGs have the advantage of shorter reaction time, 
ambient conditions, and requires fewer equivalents (4-5 eq.).    O-PEGs    of    various    
lengths    are    widely    available commercially and cheaper but requires heating, 10-15 eq. 
and longer reaction times. PEGs and other water soluble moieties can  be  used  to  modulate  
solubility  and  pharmacokinetics,[28] conversely  secondary  targeting  groups  such  as  
sugars  are readily affixed to the 4‘ position using the same chemistry.[2, 15, 25] The  N-
hydroxysuccinamide  ester  is  widely  used  to  form stable   covalent   amide   bonds   
efficiently,   but   the   linking chemistry at the end of the tether can also be readily changed 
to accommodate other common conjugation chemistries, e.g. esters,  disulfides,  thioureas  
and  different  click  groups.  Since chlorins strongly bind most metal ions, these ions can be 
readily incorporated into 3, 4, 5   to modulate the   photophysical properties: e.g. Zn2+  or 
Pt2+  to enhance intersystem crossing to the triplet manifold for PDT, Ni2+ to enhance 
internal conversion for  photothermal  applications,  64Cu2+ for  positron  emission 
tomography  imaging.  This molecular design is amenable to attaching chlorins to surfaces 






































Figure 2.1 Removing one double bond on a porphyrin results in a chlorin, while removing 
two double bonds on the opposite pyrroles yields a bacteriochlorin and on the adjacent 


















































Figure 2.2 Core chlorin platform in green is modified by successive click chemistries to 
append the PEG groups and the biomolecule for targeting and tracking, and chelated metal 






























X = S or O
R= PEG
Y = C=O


























The UV-visible and fluorescence experiments were of our approach to provide a full 
characterization of the prepared chlorins moieties. The UV-visible and fluorescence data gathered 
from the spectra of parent TPPF20 and chlorin derivatives is presented in Table 2.1, (Figure 2.4, 
2.5). The UV-visible spectrum of 2 in CH2Cl2 has a lowest energy Q band at Amax = 652 
nm. The Soret bands for the S-PEG (4 and 7) and O-PEG (5 and 8) derivatives are blue 
shifted by about 5 nm, indicating small electronic differences arising from the electronic 
interaction b e t w e e n  t h e  substitution of the four -F groups with four –S-PEG and –O-
PEG groups.  
Table 2.1 UV-visible and fluorescence 
Cpd[a] Solvent UV-visible λmax nm Fluorescence[b] λmax nm (τ ns) 
TPPF20 DMSO 410, 508, 582 637, 702[c] 
2 CH2Cl2 412, 506, 597, 652 656, 720 (6.6) 
N-Me-chlorin CH2Cl2 411, 506, 596, 652 656, 720 (6.6) 
3 CH2Cl2 405, 503, 597, 651 ------------- 
4 CH2Cl2 412, 506, 597, 651 657, 725 (6.6) 
5 CH2Cl2 410, 506, 597, 652 657, 725 (6.7) 
7 CH2Cl2 408, 504, 598, 652 657, 725 (6.7) 
8 CH2Cl2 405, 502, 596, 652 655, 725 (6.6) 
 
In CH2Cl2 in 1 cm cuvette [a] ca. 1 µM, [b] 0.1 µM, λex at Soret band λmax,, the FWHM of the 725 
nm peak is ca. 50 nm, lifetime, τ ± 0.1 ns by time correlated single photon counting. Fluorescence 





Figure 2.4 UV-visible spectra of published chlorin N-Me and chlorin NH compound 2, the S-
PEG-chlorin 4, and the O-PEG-chlorin compound 5 and the corresponding chlorin NHS esters 7 
























Figure 2.5 Fluorescence emission of published chlorin N-Me and chlorin NH compound 2, the S-
PEG-chlorin 4, and the O-PEG-chlorin compound 5 and the corresponding chlorin NHS esters 7 















Figure 2.6 UV-Vis absorption spectra of OPEG-chlorin 8 (brown) and OPEG-chlorin-lysozyme 
conjugate after SEC (green). Red: lysozyme in DMSO; black DMSO. Spectra recorded in a 















Figure 2.7 SDS-PAGE for conjugation of S-PEG-Chlorin to lysozyme in DMSO. Lane 1: 
Molecular weight marker. 2: Free lysozyme. 3: Free S-PEG-chlorin. 4: Crude product reaction 1:1. 
5: Crude product reaction 1:10. A: Visualization of chlorin fluorescence after excitation at 365 nm 
B: Visualization of protein after staining with Coomassie Blue C: Overlay UV/Coomassie. Data 













Figure 2.8 SDS-PAGE for conjugation of O-PEG-chlorin to lysozyme in DMSO. Lane 1: 
molecular weight marker. 2: Free lysozyme. 3: Free Chlorin. 4: Crude product reaction 1:1. 5: 
Crude product reaction 1:10. A: Visualization of chlorin fluorescence after excitation at 365 nm 
B: Visualization of protein after staining with Coomassie Blue. C: Overlay UV/Coomassie. Data 














Figure 2.9 Enzymatic activity assay of A) lysozyme in DMSO; B) O-PEG-chlorin- 
lysozyme conjugate in DMSO using Micrococcus lysodeikticus in 66 mM potassium 

















Figure 2.10 20% denaturing polyacrylamide gel for A) the O-PEG-chlorin-DNA conjugate, B) 
the S-PEG-chlorin-DNA conjugate. Gels are stained with Nuclistain to visualize DNA and 




Figure 2.11 Nondenaturing PAGE for bioconjugation of O-PEG-Chlorin to lysozyme in DMSO 
after SEC. Lane 2: Free lysozyme. Lane 4: Fraction-1. Lane 6: Fraction-2. Lane 8: Fraction-3. A: 
Visualized with UV light at 365nm before staining with Coomassie. B: After staining with 










































Figure 2.12. Fluorescence images of DNA-chlorin conjugate on the day of fixing MDA-MB-231 
cells using 4% paraformaldehyde. a-f are bright field images and g-l are overlays at 0, 1, 2.5, 5, 









































Figure 2.13. Fluorescence images of DNA-chlorin conjugate after 7 days of fixing MDA-MB-231 
cells using 4% paraformaldehyde. a-f are bright field images and g-l are overlays at 0, 1, 2.5, 5, 








In summary, we have provided a synthetic route for the facile preparation of chlorin 
platforms that can be used in imaging experiments, bioanalytic applications and it can provide 
treatment by using photodynamic therapy approach.[31] Our synthetic strategies take advantage 
of click reactions to attach polyethylene glycols (PEGs).[21] Thus, the well-known properties of 
PEGs to modulate small molecule solubility, pharmacokinetics, targeting, and reactivity were 
also readily exploited. The DNA-chlorin conjugate induces MDA-MB-231 cell death LD50 
of ~ 5 nM by an unknown mechanism, whereas neither the chlorin by itself, nor the DNA by 













Table 2.2 Compound 2, N-H chlorin compared to the N-CH3 derivative, proton NMR 
assignments and comparison to literature 
 
a 1H NMR (600.07 MHz, CDCl3, Si(CH3) = 0 ppm), Hirohara and coworkers.[3]  
b 1H NMR (500 MHz, CDCl3). 
c chemical shifts (ppm) in CDCl3 , multiplicity (number of protons), Tome and coworkers.[32]  
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Table 2.3 Compounds 2 compared to the Pd(II) and N-CH3 complex, C-13 NMR assignments 
and comparison to literature. 
Hiroharaa PPM Drainb PPM 
C1, C4, C11, C14-α-
pyrroleC 
156.04-155.83 C-F pentafluorophenyl 151.77 (ortho) 
C2C6-PhC, C3C5-
PhC 
148.97-144.55 C15 146.31 
C9, C16-α-pyrroleC 138.46 Quaternary, 
pentafluorophenyl 
145.59 
C6, C19-α-pyrroleC 137.69 C10 144.31 
C8, C17-β-pyrroleC 131.92 Quaternary, 
pentafluorophenyl 
143.59 
C12, C13-β-pyrroleC 127.85 C14 142.21 
C7, C18-β-pyrroleC 127.34, 127.14 C16 140.16 
C4-PhC 121.44 C-F pentafluorophenyl 139.26 (para) 
C1-PhC 111.67 C5, meso 138.17 
C10, C15, mesoC 109.49 C19 137.45 
C5, C20, mesoC 98.22 C20, meso 136.12 
N-CH2 63.60 C1 135.46 
C2, C3-β-pyrroleC 50.74 C-F pentafluorophenyl 134.17 (para) 
  C-F pentafluorophenyl 131.34 (meta) 
  C-F pentafluorophenyl 126.31 (ortho) 
  C-F pentafluorophenyl 122.84 (meta) 
  C12, C13 114.69, 114.24 
  C17 105.30 
  C18 96.07 
  N-CH2 27.99 




a 13C NMR (CDCl3, 100.40 MHz, CDCl3 = 77 ppm) 









Table 2.4 Compounds 2 compared to the Pd(II) and N-CH3 complex, F-19 NMR assignments 












a19F NMR (376 MHz, CDCl3, CF3CO2H = -76.50 ppm) 
b19F NMR (376 MHz, CDCl3) 
 
The F relaxation of the 13C by NOE is not efficient and coupling J 13C-19F = 1 to 25 Hz, resulting 
in weak multiplets in the carbon spectrum.[33]  
Doubling of the peaks for chlorins is due to the two tautomeric forms of the pyrrole NH, but 




































-135.31 1F, brs, 2,6-
PhF 
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Figure A2.1. Compound 2, Solvent used: Deuterated chloroform (CDCl3, 7.19 ppm) was used 








Figure A2.2. Compound 3, Solvent used: Deuterated chloroform (CDCl3, 7.25 ppm) was used as 























































































Figure A2.7. 1H NMR expansion of a crude mixture of compound 4 and 7, showing the bridgehead 
hydrogens and SPEGs. THF appears at 2.69-2.64 ppm.  
 











Figure A2.9. Compound 2 in CDCl3, approx. 77.16. Expansion (see tables 2.2-2.4 for 





















Figure A2.11. Compound 3 in CDCl3 (approx. 77.16). See tables 2.2-2.4 for assignments and 
comparison to literature.  
  
 






















Figure A2.13. Compound 5 in CDCl3 expanded.  
  
 










Figure A2.14. Compound 5 in CDCl3 expanded. 
  
 






Figure A2.15. Compound 5 in CDCl3 (approx. 77.16) expanded.  
 


















































































































































































































































































Figure A2.28.  HRESI-MS of the conjugate from HPLC. The second peak in the HPLC is the 











Figure A2.29. The deconvoluted HRESI-MS of lysozyme is 14,305.82 from 7.2 buffer. 
Deconvolution of the HRESI-MS of the fractions from the conjugation reaction using the O-PEG-





















DIVERGENT SYNTHESIS OF TWO NEW CHLORINS UNDER 





Though multifunctional chlorins have many potential biomedical and material applications, the 
synthesis of chlorins is a refractory obstacle in terms of specificity, high yield and derivatization. 
In this scenario, the facile and rapid routes are key for the development of a library of compounds 
that possess privilege porphyrinoid cores. We demonstrate the syntheses of a new NH-chlorin, a 
NMe-chlorin, and a new chlorin dimer which are rapid and controllably accessed from 5,10,15,20-
tetrakis-(2,3,4,5,6-pentafluorophenyl)-porphyrin (TPPF20) by merely changing concentration and 
the mole ratios of the reagents using either microwave or thermal heating. Our proposed 
mechanistic route explains the formation of a key N-hydroxymethyl-chlorin intermediate 
generated from the reaction of TPPF20 and an alternative dipolarophile azomethine ylide. 
Furthermore, microwave irradiation appears to have an advantage over classical thermal heating 
in terms of reaction times.  
 
 
                                                          
2 Adapted from reference 1.Bhupathiraju, N.V.S.D.K., Gonzales, J., Hart, D., Yuen, M., Samarxhiu, B., Maranan, M., Shi, 




High reaction rates, target selectivity, and superior product yields are common features 
exhibited by microwave irradiation methods in organic chemistry.[2-4]  For example, microwave-
facilitated Diels-Alder reactions on porphyrins are reported.[5] However, there are few reports on 
the use of microwave irradiation for the synthesis of chlorins from the parent porphyrin.[5, 6]  
Porphyrins react with azomethine ylides in thermal-assisted cycloaddition reactions to afford 
chlorins,[7, 8] but the procedure is limited by undesired side products, long reaction times, and 
lack of substrate versatility. On our quest to overcome these barriers, we decided to employ 
microwave heating.[2, 9]  
The general idea and motivation for the development of these types of chromophores relies 
on their tunable photonic properties.[10] For instance, the free base chlorin part of the platform 
enables theranostics: both detection via fluorescence using low power light and treatment via 
photodynamic therapy (PDT) using higher power light.[11, 12] Furthermore, Pt(II) porphyrins 
have nearly 100%, triplet quantum yields that enable the mapping of oxygen concentrations or 
further enhance PDT efficiency.[13, 14] Since porphyrins are strong chelators, it is possible to 
incorporate radionuclides for positron emission tomography (PET) imaging, e.g. 64Cu(II) (t½=12.7 
h) or 89Zr(IV) (t1/2=3.3 d).[15-17] PET provides a complementary imaging method to luminescence 
or magnetic resonance imaging (MRI) to trace the pharmacokinetics of the conjugates.[16, 18]  
Herein we compare microwave to thermal heating of a reaction between 5,10,15,20-
tetrakis(2,3,4,5,6-pentafluorophenyl)porphyrin (TPPF20) and an ylide formed from glycine and 
paraformaldehyde. We find that the concentration and mole ratio of ylide (Scheme 3.1) to TPPF20 
determine the products: chlorins with an N-H pyrrolidine or an N-methyl pyrrolidine fused to the 
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macrocycle. This was later confirmed by our experiments and supported by our proposed 
mechanism (Scheme 3.2) 
Oxidative or reductive removal of one of the 11 double bonds on porphyrins yields a 
chlorin. Natural and synthetic chlorins are important since they possess unique photophysical 
properties compared to the parent porphyrin, such as enhanced absorption of red light and greater 
fluorescence quantum yield (Table 3.1).[19] The photophysical properties can be exploited for 
biomedical functionalities, for example as photosensitizers for antimicrobial (Fig. 3.1A),[20-22] 
antiviral (Fig. 3.1B),[20] and cancer therapy (Fig. 3.1C).[14] Chlorins strongly absorb 650 nm 
light, which penetrates further into tissues, so they possess other interesting biomedical 
applications.[21] Chlorins have an optimal balance between fluorescence quantum yield and 
intersystem crossing to the triplet state, which is energetic enough to sensitize the formation of 
singlet oxygen (1O2)[23-25] and other reactive and toxic oxygen species to effect photodynamic 
therapy (PDT) by oxidizing biomolecules such amines and aromatics side chains in proteins, the 
double bonds in lipids, phosphate backbone and the heterocycles of DNA and RNA, flavonoids, 













demonstrated complementary features to porphyrins, these characteristics make chlorins attractive 
for potential biomedical applications. Furthermore, the greater fluorescence quantum yields and 
stability to bleaching enables chlorins to be used as fluorescent tags or trackers in biochemistry, 
and in fluorescence-guided surgeries.[8, 10, 13]  
Despite their biological importance and potential applications, chlorins and their medicinal 
attributes have not been robustly investigated due to a lack of consistent and facile synthetic route 
to derivatives with tailored physical chemical properties, such as excellent solubility, selectivity, 
and appended biotargeting motifs.[27] While other routes are employed for the synthesis of the 
chlorin core, for example the oxidative methods of Brückner and coworkers,[28] the addition of a 
pyrrolidine ring via 1,3 dipolar cycloaddition across a pyrrole has several advantages, including 














Figure 3.1. Porphyrinoids that possess different photophysical properties. The bold line 
indicates the missing double bond(s).  
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of N-methylpyrrolidine chlorins using 1,3-dipolar cycloadditions with sarcosine based ylides as 
starting materials that facilitates the cycloaddition.[8, 29, 30] However, this approach can be quite 
laborious at large quantities. Another issue with the synthesis of chlorins is the reactivity of the 
four pyrrole double bonds; this drawback will cause the inevitable formation of unwanted side 
products – mostly the isobacteriochlorin.[19] This bis-adduct problem affects the yields of the 
required products, so diminishes the overall objective to prepare and to have access to chlorin types 

















Scheme 3.2. Routes to the NH-chlorin, the NMe-chlorin, and the chlorin dimer using the 
divergent ylides. The scheme is the first mechanism based proposed that explains the formation 
of these chromophores. The mechanism features what we propose a Canizarro-type of reaction 
that supports the NH-chlorin and the chlorin dimer from the same intermediate 5’. 
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3.2 Experimental Procedure 
Materials and methods 
General 
1H and 13C solution NMR spectra were recorded using Bruker 500 MHz (spectrometer 
operating at 500 MHz for 1H; 125 MHz, for 13C), and 19F solution NMR spectra was recorded 
using Bruker 400 MHz. CDCl3 was used as solvent and TMS as internal reference; the chemical 
shifts are expressed in (ppm) and the coupling constants (J) in Hertz (Hz). Trace solvent impurities 
(e.g. water at approx. δ 1.6 ppm, dichloromethane (DCM) at approx. δ 5.2 ppm in 1H NMR spectra) 
are indicated. High Resolution Electrospray Ionization Mass Spectra (HRESIMS) were obtained 
using an Agilent 6520 Q-TOF instrument and using CH2Cl2 as a solvent. The UV-vis spectra were 
recorded using CH2Cl2 as solvent, on a Perkin-Elmer Lambda 35 UV-visible spectrometer. The 
fluorescence spectra were taken on a HORIBA FL-3 fluorometer, using CH2Cl2 as solvent. 
Reagent grade chemicals and solvents were purchased from Sigma-Aldrich Inc. or Fisher 
Scientific Inc. Reactions were monitored by TLC with Analtech Uniplate silica gel G/UV 254 
precoated plates (0.2 mm). TLC plates were visualized by UV (254 nm), and by iodine vapor. 
Preparative thin-layer chromatography was carried out on 20x20 cm glass plates coated with silica 
gel (1 mm thick). A CEM microwave reactor was used. 
 
Synthesis of 4 under Microwave Conditions 
In general, the microwave irradiation was carried out in a microwave reaction vial. 
Compound 1 (1 mg, 1 µmol) and compound 2 (1 mg, 7.4 µmol) were dissolved in chlorobenzene 
(3 mL, 0.33 mM) under N2, unless stated otherwise. The mixture was irradiated in a CEM 
microwave reactor for 5 minutes (x4) with 1 minute intervals between heating cycles at 130 oC 
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with the power level at 200 W. After cooling to room temperature, the reaction mixture was 
transferred directly to a preparative layer UV 254 plate. The solvent system for the separation was 
CH2Cl2, which upon scratching out from plate was dissolved and extracted in 50:50 
CH2Cl2/methanol solution to later be vacuum filtered and evaporated to furnish compound 4 and 
compound 5 as dark green powders. 
 
Synthesis of 4 under Thermal Conditions 
To a solution of a 100 mg of porphyrin (TPPF20, 103 µmol) dissolve in 10 mL of 
chlorobenzene, 15.4 mg of glycine (205 µmol) and 6.1 mg of paraformaldehyde (205 µmole) were 
added and heated at 110 oC for 3 hours. Successive aliquots of the ylide mixture of glycine (15.4 
mg, 205 µmol) and paraformaldehyde (6.1 mg, 205 µmol) were prepared and added to the reaction 
mixture every 5 h, for 30 h. Then the reaction mixture was cooled down to room temperature and 
loaded on top of a flash chromatography column filled with silica gel. During the purification, 
petroleum ether was the eluent to remove the unreacted TPPF20, which can be recycle and reused 
for the additional dipolar cycloaddition reactions after removing the petroleum ether. The column 
was then eluted with a solution of petroleum ether/ethyl acetate (90:10) to afford 56 mg (53%) of 
a crude dark green NH-chlorin product, 20 mg (18%) of a crude green NMe-chlorin product and 
15 mg (12%) of a crude mild dark green chlorin dimer. 
Compound 4 
1H NMR (500 MHz, CDCl3) δ 8.64 (d, J=5 Hz, 2H), 8.41 (s, 2H), 8.30 (d, J=4 Hz, 2H), 
5.14 (s, 2H), 3.28-3.25 (dd, J1=5, J2=10 Hz, 2H), 2.27-2.24 (dd, J1=5, J2=10 Hz, 2H), -1.95 (s, 
2H); 13C NMR (125 MHz, CDCl3) δ; 151.77, 146.31, 145.59, 144.31, 143.59, 142.21, 140.16, 
139.26, 138.17, 137.45, 136.12, 135.46, 134.17, 131.34, 126.98, 122.84, 114.69, 114.24, 105.30, 
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95.67, 51.32, 27.99; 19F NMR (376 MHz, CDCl3): δ -135.29 to -136.80 (m, 8F, Ar-m-F), -150.96 
to -151.64 (m, 4F, Ar-p-F), -157.21 to -161.28 (m, 8F, Ar-o-F). HRMS (refer to Appendix)  m/z 
calcd for C46H15F20N5 ([M+H]+), 1018.1081, found 1018.1091; calcd for C46H15F20N5 ([M+Na]+),  
1040.0900, found 1040.0908.  
Compound 5 
1H NMR (500 MHz, CDCl3) δ 8.64 (d, J=5 Hz, 2H), 8.41 (s, 2H), 8.30 (d, J=4 Hz, 2H), 
5.14 (s, 2H), 3.28-3.25 (dd, J1=5, J2=10 Hz, 2H), 2.27-2.24 (dd, J1=5, J2=10 Hz, 2H), 2.12 (s, 3H) 
-1.95 (s, 2H); 13C NMR (125 MHz, CDCl3) δ; 151.77, 146.31, 145.59, 144.31, 143.59, 142.21, 
140.16, 139.26, 138.17, 137.45, 136.12, 135.46, 134.17, 131.34, 126.98, 122.84, 114.69, 114.24, 
105.30, 95.67, 51.32, 40.96, 27.99; 19F NMR (376 MHz, CDCl3): δ -135.29 to -136.80 (m, 8F, Ar-
m-F), -150.96 to -151.64 (m, 4F, Ar-p-F), -157.21 to -161.28 (m, 8F, Ar-o-F). HRMS (refer to 
Appendix) m/z calcd for C47H17F20N5 ([M+H]+), 1032.1081, found 1032.1242; 
Compound 6 
1H NMR (500 MHz, CDCl3) δ 8.76 (d, J=5 Hz, 2H), 8.52 (s, 2H), 8.42 (d, J=4 Hz, 2H), 
5.29 (s, 2H), 3.73 (s, 2H), 3.22 (bs, 4H), 2.54 (bs, 4H), -1.80 (s, 4H); 13C NMR (125 MHz, CDCl3) 
δ; 151.77, 146.31, 145.59, 144.31, 143.59, 142.21, 140.16, 139.26, 138.17, 137.45, 136.12, 135.46, 
134.17, 131.34, 126.98, 122.84, 114.69, 114.24, 105.30, 95.67, 51.32, 41.20, 27.99;  HRMS (refer 






3.3 Results and Discussion 
The goal of the present work was to optimize the yield of the NMe-chlorin and minimize 
unwanted side products such as the formation of isobacteriochlorin and bacteriochlorin. Secondly, 
we wanted to develop the N-H chlorin as another attachment point because chiral substituents 
elsewhere on the macrocycle results in diastereomers at the pyrrolidine bridging positions.[8, 19] 
All these efforts appeared to diminish at first when at least five spots where observed on thin layer 
chromatography (TLC) experiments and yields were low. These drawbacks prompted us to 
hypothesize that microwave heating would improve the overall efficiency of formation of the 
NMe-chlorin, and provide access to the NH-chlorin.  During this endeavor, we unexpectedly found 
that we can make both the NMe-chlorin and the NH-chlorin from the same starting reagents: 
TPPF20 and the ylide formed from glycine and paraformaldehyde (Scheme 3.1). Conventional and 
microwave heating give somewhat similar results. The advantage of using glycine as a starting 
material rather than sarcosine, is that it significantly reduces the cost of preparation of the NMe-
chlorin. 
We propose a mechanism to explain the formation of the NH-chlorin (4), the NMe-chlorin 
(5), and a methylene bridged chlorin dimer (6), which is supported by the MS spectra (Figure 3.1). 
We theorize that a unique ylide azomethine formation is required for the reaction, via a double 
reaction attack of glycine to the aldehyde to form the dipolarophile (Scheme 3.1). The resulting 
azomethine ylide (1) reacts with the alkene bond of TPPF20 to afford the aminal intermediate. At 
the elevated temperatures used in the reaction, the aminal intermediate loses an aldehyde to afford 
the NH-Chlorin (2). Alternatively, the intermediate can dehydrate to transiently form an imine 
chlorin cation, which then can react with another hydrated formaldehyde in a Cannizzaro-type 
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reaction to yield the NMe-chlorin, or react with another NH-chlorin to yield the methylene bridged 
chlorin dimer 6, (Scheme 3.2). 
The proposed mechanism is supported by the concentration and mole ratio dependence of 
the products formed, which are readily separated by silica gel column chromatography. In 
comparison of the thermal vs. microwave heating, all yields reported are isolated, and compounds 
2, 3, and 4 are characterized by UV-visible and fluorescence (Table 3.1), NMR, and mass 
spectrometry (Appendix). The data are an average of at least triplicate experiments.      
The thermal heating in chlorobenzene experiments indicate the yield of the NH-chlorin is 
relatively insensitive to the concentration of TPPF20 but there is an optimum mole ratio of ylide to 
the porphyrin (Table 3.2, entries 1-4), wherein the greater proportion of ylide produces more of 
the second dipolar additions to form the bacteriochlorin and isobacteriochlorin at the expense of 
the target (Table 3.2, entries 5-7).[7, 8] The 9.8:1 mole ratio of ylide to TPPF20 gives the highest 
yield and about 14% of the products are the second additions. Unreacted TPPF20 can be recycled 
with the same relative yeilds. Thus, it is preferable to sacrifice initial yield of the NH-chlorin and 
recycle the unreacted TPPF20 to avoid formation and separation of the undesired side products 
(Table 2, entry 8). 
  Unexpectedly, we found that the NMe-chlorin can be formed in the microwave heated 
reactions, so we used the thermal reactions to explore the mechanism.  With a 3-fold excess of the 
paraformaldehyde, a 39-fold excess of the ylide, and in concentrated reactions, we find that the 
NMe-chlorin is formed in addition to the isobacteriochlorin, bacteriochlorin, and a dimer (Table 
3.2, entry 11). These experiments support the proposed mechanism in Scheme 3.2. Though many 
1,3-cycloadditions with ylides exhibit weak solvent dependence, some can be greatly accelerated 
in polar solvents.[33] Here, we find that the thermal reactions are significantly more efficient in 
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chlorobenzene than in toluene, which likely arises from the presence of the hydroxyl group on 
ylide 1.  
Though the reagents contribute to the overall dielectric properties of the reaction mixture, 
chlorobenzene is considered a medium microwave absorber (loss tangent δ =0.101), and toluene a 
low absorber (loss tangent δ = 0.04).[34, 35] Considering that dielectric loss is a key factor for the 
optimal absorption of microwave energy, the reactions carried out in toluene did not show much 
improvement in yield compared to similar thermal heating reactions (see Tables 3.2 and 3.3, 
Appendix).  Thus, the chlorobenzene experiments are discussed. Note that for the microwave the 
reaction scales are ca. 4-fold smaller, and the concentration ca. half of the thermal reactions.  
The use of 5 minutes microwave irradiation of the reaction mixture furnished exclusively 
the NH-chlorin 4 (Table 3.3, entry 5). Similar trends are observed in the microwave reactions: (a) 
the higher concentration and greater mole ratio of ylide to TPPF20 favors formation of the NMe-
chlorin, the isobacteriochlorin, and the bacteriochlorin; (b) the NH-chlorin is favored in more 
dilute reactions; (c) the unreacted TPPF20 can be recycled to increase overall yield of the NH-
chlorin (Table 3.3, entry 5). This represents a significant increase of the reaction yield, a 
shortening of the reaction time, and a method to make the commonly used NMe-chlorin.  
Further attempts to enhance the overall yield of the chlorins by increasing the amount of 
time irradiated and by using concentrated staring materials resulted in the decomposition of the 
starting material and the production of NMe-chlorin (Table 3.3, entry 2). Furthermore, in contrast 
to the thermal reactions, good yields of the either the NH-chlorin or the NMe-chlorin can be 
obtained by tuning the reaction conditions, (Figure 3.2).  
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The NMe-chlorin is well established in the literature.[19, 29, 36] The NH-chlorin is a new 
entry into the palette of these dyes, but it is more susceptible to decomposition. The unexpected 
formation of the methylene-bridged (singlet 3.70 ppm) dimer provides further evidence of the 
divergent synthetic pathway. Several features of the NH-chlorin are worth noting. The NMR for 
NH-chlorin 4 is consistent with the literature data for the NMe-chlorin 3 in that both show the 
doublet of doubles or the bridgehead hydrogens at 5.2 and 5.1 ppm, respectively. The electronic 
spectra are similar,[37] indicating only small differences in the electronic communication between 
the appended pyrrolidine and the macrocycle (Table 3.1). 
 
Figure 3.2. An overview of the synthetic approach for the preparation of NH-chlorin, NMe-chlorin 




Table 3.1 UV-visible and fluorescence  
Compound UV-visible λmax nm Fluorescence λmax nm (τ ns) 
NH-chlorina 412, 506, 597, 652 656, 720 (6.6) 
NH-isobacteriochlorina 411, 506, 596, 652 656, 720 (6.6) 
NH-bacteriochlorina 405, 503, 597, 651 --     --      -- 
NH-chlorinb 412, 506, 597, 651 662, 725 (6.6) 
NH-isobacteriochlorinb 410, 506, 597, 652 662, 725 (6.7) 
NH-bacteriochlorinb 408, 504, 598, 652 662, 725 (6.7) 
NMe-chlorinb 405, 502, 596, 652 662, 725 (6.6) 
aUnder thermal conditions 
bUnder microwave conditions  
ca. 1 µM for UV-visible and 0.1 µM for emission spectra in CH2Cl2 in 1 cm cuvette, 
























Table 3.2.  NH-chlorin and NMe-chlorin yields under thermal conditions 
a paraformaldehyde:glycine = 1:1 
b paraformaldehyde:glycine 3:1,  
c for all experiments: 100 mg (103 µmol) TPPF20 in chlorobenzene at 140 °C in 














1 4 x 337a (13) 2 mL [51.5 mM] 35 0 15 
0 
40 
2 4 x 337a  (13) 4 mL [25.75 mM] 30 0 10 
0 
52 
3 4 x 337a (13) 8 mL [12.88 mM] 36 0 13 
0 
45 
4 3 x 337a (9.8) 










5 3 x 1351a (39.3) 2 mL [51.5mM] 12 8 20 
0 
40 
6 3 x 1351a (39.3) 4 mL [25.75 mM] 30 0 16 
0 
38 
7 3 x 1351a (39.3) 8 mL [12.88 mM] 32 0 30 
0 
25 
8 3 x 168a (4.9) 8 mL [12.88 mM] 40 0 0 
35 
20 
9 4 x 337b (13) 2 mL [51.5 mM] 29 2 7 
0 
38 
10 4 x 337b (13) 8 mL [12.88 mM] 36 0 5 
0 
45 
11 3 x 1351b (39.3) 2 mL [51.5mM] 2 16 15 
0 
40 





Table 3.3 NH-chlorin and NMe-chlorin yields under Microwave Conditions 
a formaldehyde:glycine = 1:1 
b reaction mixture ground in mortar and pestle 
c reaction conditions: 10 mg (10 µmol) TPPF20 in given volume of chlorobenzene, 
1 minute interval between heating cycles 
 
Furthermore, when preparing the chlorins, extra care must be paid to the synthesis, 
especially when monitoring by thin layer chromatography (TLC). The right combination of eluents 
to prepare the solvent system to elucidate the product formation is extremely important for the 
success of the synthesis. For instance, the chlorin (Rf = 0.10) in the reaction mixture will show as 
a green band after one or two-hour reaction on the bottom of the TLC plate, when using 100% 
CH2Cl2 as a solvent system but with a tail and material that does not move. If the same reaction 
mixture (green band) is spotted using 20% acetone in hexanes as a solvent system, the chlorin (Rf 
= 0.50) will appear in the middle of the TLC plate as a green band. Other solvents, such 3% 
 
aliq. x µmol ylide 1a 
(mol 1/TPPF20) 





1 1 x 135 (135) 
1 mL (10 mM), 200 W, 
130 oC, 4 x 5 min. 
5 65 5 28 
2 3 x 135 (40) 
2 mL (5 mM),  250 W, 
130 oC, 3 x 10 min. 
5 60 0 25 
3 1 x 270 (27) 
solvent free,b 200 W, 
150 oC, 1 x 10 min. 
15 25 0 50 
4 1 x 270 (27) 
2 mL (5 mM), 200 W, 
130 oC, 4 x 5 min. 
30 15 5 50 
5 1 x 135 (135) 
1 µmol, 3 mL (0.33 mM), 
200 W, 130 oC, 












methanol in CH2Cl2 or 20% ethyl acetate in hexanes, provide unsuccessful separations for the 
chlorin to be isolated as a single spot.  
After a 25-hour reaction, our first impression was that the chlorin appears as one band, so 
our desired compound was the predominant product of the reaction. We realized first by hypothesis 
and then experimentally that the green band that appear to be the chlorin also was comprised of a 
second band. This band was only resolved when the separation was carried out by using a 
preparatory TLC plates. The TLC plate was left out overnight for separation, and the second green 
band (Rf = 0.53) was observed just above the major green band. After this event, our first 
impression was that the NH-chlorin and the chlorin dimer overlap making the separation tedious 
and laborious. The best separation of the NH-chlorin and the chlorin dimer occurs when we use a 
preparatory TLC and not by means of column chromatography. 
3.4 Conclusions 
The selective synthesis of two new chlorins in good yields from the same starting reagents 
is possible by adjusting the concentrations and the mole ratios of the reagents. This study 
demonstrates the utility of microwave heating for rapid dipolar cycloaddition in the synthesis of 
porphyrinoids with saturations at the double bond of the pyrrole of the porphyrin in comparison to 
the thermal method. From the point of view of the development of a synthetic for chlorins with 
regioselectivity, we show that ylides prepared from glycine and paraformaldehyde furnish both the 
chlorin featuring fused pyrroline and pyrrolidine free base (NH) and the chlorin featuring a fused 
pyrroline and pyrrolidine NMe.  
We have also proposed and evaluated a mechanism that explains the formation of the 
molecules synthesized, where the ylide is formed after a double attack of the glycine to the 
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paraformaldehyde, in which the second attack of the already alcoholic glycine affords a more 
stable alcoholic ylide, the aforementioned moiety will react in the dipolar cycloaddition. Of 
particular importance for the success of our synthetic approach was the understanding and 
justification of a stable ylide that was formed between the paraformaldehyde and glycine. This 
alcoholic ylide took some time to be proposed in the mechanism because the classical route used 
sarcosine (secondary amine) for the preparation of chlorin of this type. This success with the 
mechanism was fruitful because we later were able to rationalize other possible products in the 
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Figure A3.1. Compound 2, Solvent used: Deuterated chloroform (CDCl3, 7.25 ppm) was used as 




































































Figure A3.4. Compound 15, Solvent used: Deuterated chloroform (CDCl3, 7.25 ppm) was used 































































Figure A3.7. Compound 16, Solvent used: Deuterated chloroform (CDCl3, 7.25 ppm) was used 


































































































































The emergence of folic acid receptors as potential targets for cancer imaging has garnered attention 
in the last decade. Two carboxylic acid tails are present in the folic acid moiety. Chlorins are 
porphyrinoids that are armed with beneficial photophysical properties that can be exploited in 
biomedical applications such photodynamic therapy (PDT), fluorescence imaging and positron 
emission tomography (PET) imaging. Taking these together, we demonstrate herein the 
preliminary steps for a synthetic approach that uses an alkane amino terminated linker that can be 
appended to the carboxylic acid groups of the folic acid. Our approach shows an initial facile route 
for the preparation of the amide bond used to conjugate the folic acid and the chlorin. Furthermore, 
the reputed properties of the folic acid and of the chlorin afford an enhanced conjugate capable of 




                                                          
1 Adapted from reference 1. Gonzales, J., Carney, B., Hart, D., Maranan, M., Berisha, N., J., Rainer T. and Drain, C. M. 





Increasing evidence suggests that the folate receptor can be exploited for therapeutic and 
biological applications.[1] Folic acid or folate is one of the B vitamins, the acid is often used as a 
supplement by pregnant women.[2] Among the known functions of folic acids, from the biological 
aspect, are the preparation of DNA, RNA and derivatization of amino acids for their use in cell 
division.[3] In the same line, to continue our approach to detect and image cancer, it was appealing 
to embark on our idea to develop a chlorin platform as a therapeutic that is conjugated to the folic 
acid to take advantage of the attributes of the two motifs. The folate receptors are believed to be 
upregulated in several epithelial cancer forms.[1, 4] Perhaps for this reason, the folate receptors 
have emerged as an appealing target for imaging because of the abundance of folic acid receptors 
in tumors due to their overexpression in a variety of cancers including cancer in the lung, breast, 
colon-rectum, kidney and uterus.[4, 5] However, the expression of folic acid receptors in normal 
non-cancerous tissues is limited to a few sites, for instance lung, kidneys, choroid plexus, placenta 









Figure 4.1. Topology of folic acid that is comprised of pteroic acid (blue) and glutamic acid (red). 




In this scenario, the topology of folic acid is comprised of two major chemical units, 
namely, pteroate and glutamate, which together form the structure of folic acid.[8] In the past, 
researchers have attached chemotherapeutic units or prosthetic groups to folic acid, which are 
usually obtained by appending the chemical moieties to any of the two carboxylic acids. In this 
regard the attachment can occur via the alpha (α) and the gamma (γ) positions of the glutamic part 
of the folic acid.[1, 9]  
Nevertheless, it has been demonstrated that it is more effective targeting moiety when other 
chemical moieties are attached to the folic acid via derivatization at the gamma-position, which is 
sterically more accessible in comparison to the alpha-position for conjugation. In this direction, 
Wang[10] has demonstrated this idea when the folic acid was conjugated to deferoxamine. It is 
also known that regioselectivity exists between the alpha and the gamma derivatives, where the 
gamma congeners were preferred over the alpha derivatives.[10, 11] Others, for instance 
Leamon,[12] have observed equal rates of conjugation of proteins to folic acid either at the alpha 
or gamma carboxylic acid end. The aforementioned results were confirmed by Muller et al.[13] 
Folic acid and their derivatives have also been evaluated as anti-tumor agents.[14] 
Photodynamic therapy (PDT) is a “small-molecule approach” for cancer treatment that 
relies on photosensitizers that accumulate selectively in tumors and induces cytotoxicity via the 
generation of singlet oxygen or reactive oxygen species (ROS) upon irradiation by (preferably) 
tissue-penetrating wavelengths of visible light.[15-19] Current research indicates that versatile-
functional macrocycles such as those in the family of chlorins (porphyrins missing a double bond) 
are optimal platforms for the development of novel dyes that display therapeutic attributes as PDT 
agents.[20-24] More recently, it was demonstrated that chlorins can serve both as a PDT agent and 
as a modality for fluorescence or PET imaging.[25, 26] Thus, theranostic chlorins eliminate the 
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differences that may occur in specificity, uptake, and distribution between separate compounds or 
constructs for imaging and therapy.[27, 28] The overall goal of this project is to take advantage of 
the intrinsic photophysical attributes of chlorins and of the targeting potential of folic acid as a 
viable strategy towards imaging, treatment and post-treatment monitoring of a variety of 
cancers.[29] Chlorins and related macrocycles are not robustly investigated as theranostic agents, 
and there are a few reports of their use as multifunctional platforms.[27] Chlorins such as those 
proposed below have ca. 35% singlet oxygen quantum yields, making them good photosensitizers 
for use in PDT, but also have ca. 30% fluorescence quantum yields for diagnostic imaging.[30] 
Chlorins possess a strong absorbance at 650 nm where tissue penetration of light is at its maximum 
and the wavelengths of light are energetic enough to produce the photodynamic effect.[24, 31]   
In this regard, chlorins are attractive platforms for designing potent photosensitizer 
agents.[27, 28, 32] For effective PDT and imaging, the chlorin dye is required to be armed with 
functional groups at specific sites to target disease, modulate solubility, and dictate 
pharmacokinetics. Thus, the fluorescence and photosensitizing properties of chlorins can be 
exploited by appending targeting motifs such as sugars, aptamers, antibodies, or anti-cancer drugs 
to direct the conjugate to diseased sites to effect therapy and diagnostic imaging. In this chapter, 
we report our efforts for the synthesis of a chlorin platform that will be able to conjugate with other 
biologicals of importance. The alkane amino terminated tether of the chlorin will enable the 
chromophore to effectively be appended to folic acid via amide bond formation. 
In this chapter, as a sequel of previous work, we report the concise preparation of a chlorin 
that features an alkane-amino terminated linker. For the synthesis, we started from 5,10,15,20-
tetrakis-(2,3,4,5,6-pentafluorophenyl)-porphyrin (TPPF20), which was transformed to 






























Scheme 4.1. (i) 1 equiv. 4-Bromo butyronitrile, ACN, K2CO3, reflux, 1.5h, 73% yield, 
(ii) THF, LAH, 0o to r.t, 60%,   
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The free base chlorin was then reacted with a bromoalkane terminated in a nitrile group (4-
bromobutyronitrile) to furnish the chlorin appended to the alkane linker terminated in a nitrile 
moiety under reflux (Scheme 4.1).[35] This compound, 3, was then reduced to the chlorin alkane 
amine using lithium aluminum hydride (LAH). CDI (1'-carbonyldiimidazole) was used as the 
coupling reagent between the chlorin and the folic acid (Scheme 4.2).[36] 
We have developed a reliable and rapid method for the synthesis of chlorin with an alkane 
tether featuring a free base nitrogen capable of conjugating other components. Furthermore, in 
order to synergistically combine the reputed characteristics and properties of chlorin and folic acid, 
we herein provide a method for accessing a folated chlorin conjugate from this starting point, using 
simple chemistry to connect these two important molecules for their use in the aforementioned 
areas. 
As a demonstration of the sequential reactions used to make the folated chlorin dye for 
bioanalytics and theranostics, we report the preparation of a core meso perfluorophenyl chlorin 
with an aliphatic tether that features an amine group. The terminal amine is used to link the chlorin 
to the folic acid motif (Schemes 4.1 and 4.2)[35]. Furthermore, the alkane linker stabilizes the 
chlorin and prevents the platform from exhibiting diastereomerism (e.g. when the folate is attached 
to one of the meso aryl groups). 
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4.2 Experimental Procedure 
Materials and methods: 
General 
1H and 13C solution NMR spectra were recorded using a Bruker 500 MHz spectrometer 
operating at 500 MHz for 1H and 125 MHz for 13C. 19F solution NMR spectra was recorded using 
a Bruker 400 MHz. CDCl3 was used as solvent and TMS as internal reference; the chemical shifts 
are expressed in (ppm) and the coupling constants (J) in Hertz (Hz). Trace solvent impurities (e.g. 
water at approx. δ 1.6 ppm, dichloromethane (DCM) at approx. δ 5.2 ppm in 1H NMR spectra) are 
indicated. High Resolution Electrospray Ionization Mass Spectra (HRESIMS) were obtained using 
an Agilent 6520 Q-TOF instrument and using CH2Cl2 as a solvent. The UV-vis spectra were 
recorded using CH2Cl2 as solvent, on a Perkin-Elmer Lambda 35 UV-visible spectrometer. The 
fluorescence spectra were taken on a HORIBA FL-3 fluorimeter, using CH2Cl2 as solvent. Reagent 
grade chemicals and solvents were purchased from Sigma-Aldrich Inc. or Fisher Scientific Inc. 
Reactions were monitored by TLC with Analtech Uniplate silica gel G/UV 254 precoated plates 
(0.2 mm).  TLC plates were visualized by UV (254 nm), and by iodine vapor. Preparative thin-
layer chromatography was carried out on 20x20 cm glass plates coated with silica gel (1 mm thick). 
Adapted from reference 1. 
 
Synthesis of Compound 2 
Glycine (77 mg, 1.05 mmol) and paraformaldehyde (30.8 mg, 1.05 mmol) were mixed in 
situ for 5 min to afford the azomethine ylide adduct (107 mg). To a stirred solution of 5,10,15,20-
tetrakis-(2,3,4,5,6-pentafluorophenyl)-porphyrin TPPF20 (100 mg, 0.102 mmol) dissolved in 
chlorobenzene (8 mL), the prepared azomethine ylide (25 mg) was added in 4 aliquots every 2 
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hours and allowed to react at 145 oC under nitrogen atmosphere for a total of 8 hours. After cooling 
to room temperature, chlorobenzene was evaporated under reduced pressure and the product was 
dissolved in 4 mL of DCM for purification by silica gel. DCM was used to get the unreacted 
TPPF20, followed by 7% EtOAc in DCM as eluent to furnish 36% pure 2 (37.5 mg, 0.0367 mmol) 
as a dark green solid. 1H NMR (500 MHz, CDCl3) δ 8.64 (d, J=5 Hz, 2H), 8.41 (s, 2H), 8.30 (d, 
J=4 Hz, 2H), 5.14 (s, 2H), 3.28-3.25 (dd, J1=5, J2=10 Hz, 2H), 2.27-2.24 (dd, J1=5, J2=10 Hz, 2H), 
-1.95 (s, 2H); 13C NMR (125 MHz, CDCl3) δ; 151.77, 146.31, 145.59, 144.31, 143.59, 142.21, 
140.16, 139.26, 138.17, 137.45, 136.12, 135.46, 134.17, 131.34, 126.98, 122.84, 114.69, 114.24, 
105.30, 95.67, 51.32, 27.99; 19F NMR (376 MHz, CDCl3): δ -135.29 to -136.80 (m, 8F, Ar-m-F), 
-150.96 to -151.64 (m, 4F, Ar-p-F), -157.21 to -161.28 (m, 8F, Ar-o-F). HRMS (refer to Appendix) 
m/z calcd for C46H15F20N5 ([M+H]+), 1018.1081, found 1018.1091; calcd for C46H15F20N5 
([M+Na]+),  1040.0900, found 1040.0908. 
Synthesis of Compound 3 
To a solution of compound 2 (30 mg, 0.03 mmol, 1 equiv.) dissolved in 3 mL of acetonitrile, 
K2CO3 (81 mg, 0.59 mmol, 2 equiv.) was added and stirred for 5 min. 4-bromobutyronitrile (30.00 
µL, 0.30 mmol, 1.0 equiv.) was added to the reaction mixture and allowed to reflux for 1.5 h. 
Acetonitrile was removed under reduced pressure, and the crude mixture was dissolved in CH2Cl2 
(8 mL) and washed with water (8 mL). The organic layer was isolated, evaporated and 
concentrated in vacuo. The crude mixture was purified by flash column chromatography over 
deactivated silica gel using 20% acetone in hexanes as the eluent to furnish pure compound 3 as a 
green solid (22 mg, 73% from 2). 1H NMR (500 MHz, CDCl3) δ 8.74 (d, J=5 Hz, 2H), 8.50 (s, 
2H), 8.41 (d, J=10 Hz, 2H), 5.40-5.50 (m, 2H), 4.18 (t, J=10 Hz, 1H), 4.11 (t, J=10 Hz, 1H), 4.00-
4.04 (m, 2H), 3.75-3.78 (dd, J1=5, J2=10 Hz, 2H), 2.53-2.60 (m, 2H), 2.34-2.45 (m, 1H), 2.13-2.18 
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(m, 1H), -1.85 (s, 2H); 13C NMR (125 MHz, CDCl3) δ; 172.51, 169.27, 153.08, 147.30, 146.53, 
145.26, 144.53, 143.37, 141.21, 140.55, 140.15, 139.09, 138.52, 137.13, 136.50, 135.48, 135.26, 
132.66, 132.62, 128.36, 128.15, 124.30, 123.82, 118.99, 115.23, 106.70, 96.95, 62.32, 50.58, 29.71, 
28.74, 24.63. HRMS (refer to Appendix) m/z calcd for C50H20F20N6 ([M+H]+), 1084.14, found 
1085.12 
Synthesis of Compound 4 
Lithium aluminum hydride, LAH, (2 mg, 0.05 mmol, 2 equiv.) was dissolved in THF (2.5 
mL) inside a round bottom flask at 0 oC for about 5 min. To the reaction mixture, a solution of 
compound 4 (30 mg, 0.03 mmol, 1.0 equiv.) in THF (1 mL) was added, stirred and reacted at 0 oC 
under inert conditions for 3 h. THF was evaporated under reduced pressure, and the reaction 
mixture was quenched with methanol (5 mL). This step was followed by the addition of water (5 
mL) to the same reaction mixture. Diethyl ether (5 mL) was added to the reaction mixture and 
isolated using a separatory funnel. The top organic layer was evaporated and concentrated in vacuo. 
The crude product was purified by flash column chromatography over deactivated silica gel using 
0.5% MeOH in DCM as the eluent to furnish pure compound 4 as a green solid (6 mg, 30% yield 
from 3). 1H NMR (500 MHz, CDCl3) δ 8.74 (d, J=5 Hz, 2H), 8.50 (s, 2H), 8.41 (d, J=10 Hz, 2H), 
5.40-5.50 (m, 2H), 4.18 (t, J=10 Hz, 1H), 4.11 (t, J=10 Hz, 1H), 4.00-4.04 (m, 2H), 3.75-3.78 (dd, 
J1=5, J2=10 Hz, 2H), 2.53-2.60 (m, 2H), 2.34-2.45 (m, 1H), 2.13-2.18 (m, 1H), -1.85 (s, 2H); 13C 
NMR (125 MHz, CDCl3) δ; 158.71, 151.65, 146.21, 145.60, 144.24, 143.63, 142.19, 140.09, 
138.22, 137.48, 136.07, 135.44, 134.50, 131.71, 131.34, 127.37, 127.00, 122.86, 114.19, 105.11, 
95.73, 52.00, 47.08, 40.11, 29..67, 21.67. HRMS (refer to Appendix) m/z calcd for C50H24F20N6 




Synthesis of Compound 5 
To a solution of folic acid (4.5 mg, 0.01 mmol, 1.1 equiv.) dissolved in THF (4 mL) was 
added to 1,1’-carbonyldiimidazole, CDI, (1.5 mg, 0.01) inside a round bottom flask. The reaction 
mixture was stirred and allowed to react at 0 oC for 1 h and at ambient temperature for an extra 1 
h. To the same reaction mixture in the round bottom flask, compound 4 (10 mg, 0.01 mmol, 1.1 
equiv.) dissolve in THF (2 mL) was added at 0 oC, stirred and allowed to react for 4 h. THF was 
evaporated to concentrate the product in vacuo. The crude compound was purified by flash column 
chromatography over deactivated silica gel using 0.7% MeOH in DCM as eluent to furnish two 
compounds, the starting material and a green spot that, based on the HRMS experiment, 














4.3 Results and Discussion 
In our approach, the chlorin that formed via a cycloaddition reaction was appended to an 
alkane tether to afford a chlorin with an aliphatic tether that features a nitrile moiety at the end. 
The dark green product was isolated by a standard column chromatography method, although 
a preparatory TLC also works well. A quick elution using an acetone/hexanes solution provides 
the desired product. Again, the resulting chlorin alkane tether-nitrile was obtained after the 
attack of a nucleophile, in this case using 4-bromobutyronitrile, in a classical nucleophilic 
substitution reaction (SN2) to afford compound 4. Other tethers with different lengths and 
functionalities are amenable as well. This route to adding the linker on the pyrrolidine was 
used to circumvent the formation of diastereomers that results from substitution of the para 
fluoro group on the phenyls with chiral moieties such as sugars.[27] 
Compound 3 was then reduced to the primary amine using lithium aluminum hydride 
(LAH). This chlorin 4 exhibits a free base nitrogen that is used to amide couple to one or both 
of the carboxylic acids present in the folic acid using a coupling reagent, in this case 1,1’-
carbonyldiimidazole. Note that the 4' fluoro groups can be substituted nearly quantitatively 
with a large menu of primary thiols, but amines and alcohols also react well at elevated 
temperatures and longer reaction times.[22, 29] In this occasion the folic acid part is soluble 
enough to make the conjugate hydrophilic. 
The NMR spectra is in agreement with the data published by others[20, 34] and with our 
recent publication (Gonzales et al.)[27] with respect to the signals present in the chlorin core in 
both 1H and 13C NMRs. For example, characteristic 1H NMR doublet of doublets at 2.27-2.24 and 
3.28-3.25 are intact for the -CH2 groups of the pyrrolidine ring.[27] For compound 3, characteristic 
alkane peaks are also present in the synthesized chromophore, for instance, a multiplet at 4.00-
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4.04. Furthermore, aromatic signals of the chlorin core appear downfield at 8.40-8.74 with respect 
to signals of the bridge-head hydrogens at 5.40-5.50. The UV-vis spectra of compounds 3 and 4 
have their lowest energy Q band at λmax = 654 nm and 656 nm, respectively. The Soret bands 
of compounds 3 and 4  derivatives are blue shifted by about 3 nm, indicating small 
electronic differences in comparison to the parent chlorin, compound 2.[21, 27, 37] 
The conjugation of a chlorin platform and folic acid is presented in this chapter. The 
facile conjugation yields a multifunctional platform for diverse photonic applications in 
biochemistry, fluorescence tracking, biology, imaging and therapeutics.[38-40] In the same 
direction, these types of chlorins form stable covalent amide bonds efficiently, but   the   linking 
chemistry at the end of the tether can also be readily changed to accommodate other common 
conjugation groups for the use of click chemistries, e.g. the free base nitrogen can be fused to 
afford an azide moiety, this approach can enable cyclooctyne click chemistry.[41]  Since 
chlorins strongly bind most metal ions, these ions can be readily incorporated into 4 and 5   
to modulate the photophysical properties: 64Cu2+ and 18F for positron emission tomography 











In summary, we present a preliminary synthesis to prepare chlorins that can be appended 
to important biological motifs using different functional groups, for instance, carboxylic acids and. 
In this route, we demonstrate the facile synthesis that bonds the chlorin to an alkane tether 
terminated in a nitrile in about an hour. The chlorin tether nitrile is further reduced with LAH to 
afford a chlorin tether amine.  
The chlorin tether amine is a particular important chromophore because it is a key 
intermediate that can easily be appended to the carboxylic acid groups to yield stable amide 
linkages or it can be further derivatized to cyclooctynes as long as the terminal amine on the chlorin 
is converted to the azide moiety for use in click chemistry. Moreover, this primary amine on the 
tether of the chlorin can also be functionalized to alcohols, thiols and isothiocyanates for other 
reactions using click chemistries.  
The overall syntheses are high yield and they are clean sets of reactions. Note that the 
polarity of the folic acid is high, this makes the resolving of the compound difficult when using 
thin layer chromatography (TLC). However, the chlorin formation, via amide bond, helps in the 
characterization, because the conjugate is less polar than both the parent folic acid and the 
precursor chlorin. 
The chlorins synthesized exhibit similar UV-vis spectra in comparison to the previous 
prepared chlorins in the lab. A signal on the blue region at around 420 nm is the characteristic 
Soret band present in chlorins. A signal on the red region at around 650 nm is also present in the 
UV-vis spectrum of the synthesized chlorins. These signals are responsible for the green color of 
the synthesized chlorins on thin layer chromatography plates using white-light illumination for 
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elucidation purposes. Both 1H NMR and 13C NMR spectra is in agreement with the spectra 
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Figure A4.1. Compound 11, Solvent used: Deuterated chloroform (CDCl3, 7.26 ppm) with 

























Figure A4.3. Compound 11 in CDCl3 expanded. The bridge head hydrogens that belong to the 











































Figure A4.7. Compound 12, Solvent used: Deuterated chloroform (CDCl3, 7.18 ppm) with 
























































































































Figure A4.11. Chlorin-folic acid conjugates, the intact mass for conjugate is 1511.30, mass 
spectrometry shows a peak at 1514.4. The chlorin dihydrofolic acid conjugate has a mass of 
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